<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">iScience</journal-id><journal-id journal-id-type="iso-abbrev">iScience</journal-id><journal-title-group><journal-title>iScience</journal-title></journal-title-group><issn pub-type="epub">2589-0042</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9436750</article-id><article-id pub-id-type="pii">S2589-0042(22)01206-8</article-id><article-id pub-id-type="doi">10.1016/j.isci.2022.104934</article-id><article-id pub-id-type="publisher-id">104934</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Distinctive populations of CD4<sup>+</sup>T cells associated with vaccine efficacy</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Woodring</surname><given-names>Therese</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Dewey</surname><given-names>Colin N.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Santos Dias</surname><given-names>Lucas Dos</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>He</surname><given-names>Xin</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Dobson</surname><given-names>Hannah E.</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au6"><name><surname>W&#x000fc;thrich</surname><given-names>Marcel</given-names></name><email>mwuethrich@wisc.edu</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="fn">5</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au7"><name><surname>Klein</surname><given-names>Bruce</given-names></name><email>bsklein@wisc.edu</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref><xref rid="fn1" ref-type="fn">5</xref><xref rid="fn2" ref-type="fn">6</xref><xref rid="cor2" ref-type="corresp">&#x02217;&#x02217;</xref></contrib><aff id="aff1"><label>1</label>From the Departments of Pediatrics, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison WI, USA</aff><aff id="aff2"><label>2</label>Internal Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison WI, USA</aff><aff id="aff3"><label>3</label>Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison WI, USA</aff><aff id="aff4"><label>4</label>Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison WI, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author <email>mwuethrich@wisc.edu</email></corresp><corresp id="cor2"><label>&#x02217;&#x02217;</label>Corresponding author <email>bsklein@wisc.edu</email></corresp><fn id="fn1"><label>5</label><p id="ntpara0010">These authors contributed equally</p></fn><fn id="fn2"><label>6</label><p id="ntpara0015">Lead contact</p></fn></author-notes><pub-date pub-type="pmc-release"><day>13</day><month>8</month><year>2022</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>16</day><month>9</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>13</day><month>8</month><year>2022</year></pub-date><volume>25</volume><issue>9</issue><elocation-id>104934</elocation-id><history><date date-type="received"><day>24</day><month>3</month><year>2022</year></date><date date-type="rev-recd"><day>23</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>8</day><month>8</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract id="abs0010"><title>Summary</title><p>Memory T&#x000a0;cells underpin vaccine-induced immunity but are not yet fully understood. To distinguish features of memory cells that confer protective immunity, we used single cell transcriptome analysis to compare antigen-specific CD4<sup>+</sup>T cells recalled to lungs of mice that received a protective or nonprotective subunit vaccine followed by challenge with a fungal pathogen. We unexpectedly found populations specific to protection that expressed a strong type I interferon response signature, whose distinctive transcriptional signature appeared unconventionally dependent on IFN-&#x003b3; receptor. We also detected a unique population enriched in protection that highly expressed the gene for the natural killer cell marker NKG7. Lastly, we detected differences in TCR gene use and in Th1- and Th17-skewed responses after protective and nonprotective vaccine, respectively, reflecting heterogeneous <italic>Ifng</italic>- and <italic>Il17a-</italic>expressing populations. Our findings highlight key features of transcriptionally diverse and distinctive antigen-specific T&#x000a0;cells associated with protective vaccine-induced immunity.</p></abstract><abstract abstract-type="graphical" id="abs0015"><title>Graphical abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="fx1"/></fig></abstract><abstract abstract-type="author-highlights" id="abs0020"><title>Highlights</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0010">Protective and nonprotective vaccines generate distinct T&#x000a0;cells in fungal infection</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0015">A strong type I interferon signal is seen among CD4 T&#x000a0;cells in protective immunity</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0020">Th1 bias is seen with protective immunity; Th17 bias with nonprotective immunity</p></list-item><list-item id="u0025"><label>&#x02022;</label><p id="p0025"><italic>Nkg7</italic>-expressing CD4 T&#x000a0;cells are enriched in protective immunity</p></list-item></list></p></abstract><abstract abstract-type="teaser" id="abs0025"><p>Immunology; Immune response; Transcriptomics.</p></abstract><kwd-group id="kwrds0010"><title>Subject areas</title><kwd>Immunology</kwd><kwd>Immune response</kwd><kwd>Transcriptomics</kwd></kwd-group></article-meta><notes><p id="misc0010">Published: September 16, 2022</p></notes></front><body><sec id="sec1"><title>Introduction</title><p id="p0045">Vaccines have saved millions of lives, eradicated fatal diseases, and proved essential to controlling emerging infectious disease threats (<xref rid="bib9" ref-type="bibr">Duclos et&#x000a0;al., 2009</xref>; <xref rid="bib15" ref-type="bibr">Galvani et&#x000a0;al., 2021</xref>; <xref rid="bib22" ref-type="bibr">Heaton, 2020</xref>). Although vaccines were initially developed without mechanistic understanding of immunity, they are now recognized to require the response of antigen-specific T&#x000a0;cells that produce cytokines to activate phagocytes, induce antibody production in memory B cells, and persist long after the initial antigen challenge. These memory T&#x000a0;cells&#x02014;including circulating effector memory T&#x000a0;cells (T<sub>EM</sub>), central memory T&#x000a0;cells (T<sub>CM</sub>), and tissue-resident memory cells (T<sub>RM</sub>)&#x02014;may be elicited by a variety of vaccine types and confer variable protection based on the route of vaccination and magnitude of the initial T&#x000a0;cell response (<xref rid="bib36" ref-type="bibr">Panagioti et&#x000a0;al., 2018</xref>; <xref rid="bib37" ref-type="bibr">Pollard and Bijker, 2021</xref>; <xref rid="bib40" ref-type="bibr">Schenkel and Masopust, 2014</xref>). In contrast to circulating antibodies, however, memory T&#x000a0;cells can be difficult to isolate from the periphery and remain poorly characterized. Given ongoing challenges in developing vaccines that induce cellular immunity against some of the most important global pathogens, a better understanding of these T&#x000a0;cells&#x02014;and what distinguishes protective from nonprotective vaccine-induced T&#x000a0;cell responses&#x02014;is a priority.</p><p id="p0050">Single cell transcriptome analysis (scRNAseq) is one tool for characterizing memory T&#x000a0;cells at the site of pathogen encounter. Whereas traditional methods classify cells by expression of a small subset of known markers, scRNAseq defines cell phenotypes agnostically, by gene expression profiles across the entire transcriptome. Often, the approach validates known differences in cell types; however, it may also expand or even challenge traditional frameworks for classifying complex populations. For instance, scRNAseq analysis groups T&#x000a0;cells from blood, lymphoid, and lung tissue by activation states distinct to known CD4<sup>+</sup> and CD8<sup>+</sup> lineages, whereas effector T helper cells responding to various colonic pathogens do not segregate into canonical Th1, Th2, and Th17 archetypes (<xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>; <xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>).</p><p id="p0055">Sequencing-based methods also identify novel cell types (<xref rid="bib48" ref-type="bibr">Stubbington et&#x000a0;al., 2017</xref>). One such cell, observed in recent scRNAseq experiments, is the type I interferon-signature T&#x000a0;cell (<xref rid="bib1" ref-type="bibr">Andreatta et&#x000a0;al., 2021</xref>; <xref rid="bib2" ref-type="bibr">Arazi et&#x000a0;al., 2019</xref>; <xref rid="bib19" ref-type="bibr">Gowthaman et&#x000a0;al., 2019</xref>; <xref rid="bib21" ref-type="bibr">Harsha Krovi et&#x000a0;al., 2020</xref>; <xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>; <xref rid="bib42" ref-type="bibr">Seumois et&#x000a0;al., 2020</xref>; <xref rid="bib43" ref-type="bibr">Singhania et&#x000a0;al., 2019</xref>; <xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>; <xref rid="bib52" ref-type="bibr">Tibbitt et&#x000a0;al., 2019</xref>; <xref rid="bib55" ref-type="bibr">Zemmour et&#x000a0;al., 2018</xref>). These cells (hereafter &#x0201c;Tis T&#x000a0;cells&#x0201d;) are distinct for the striking upregulation of multiple genes that typically are induced by type I interferons (IFN) and have well established roles in cellular responses to viral infection. However, these Tis T&#x000a0;cells have appeared across diverse immunological settings where type I interferon would not be expected, such as dust mite allergy, <italic>Alternaria</italic> sensitization, and <italic>Salmonella</italic> and <italic>Citrobacter</italic> infection (<xref rid="bib19" ref-type="bibr">Gowthaman et&#x000a0;al., 2019</xref>; <xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>; <xref rid="bib52" ref-type="bibr">Tibbitt et&#x000a0;al., 2019</xref>). Their function remains unknown.</p><p id="p0060">Herein, we compare the transcriptional phenotypes of antigen-specific CD4<sup>+</sup>T cells recalled to lungs of mice challenged with lethal pulmonary fungal infection after they received a subunit vaccine that is highly protective when given subcutaneously (SC), but not intranasally (IN). By using single cell transcriptome analysis, we uncover populations of T&#x000a0;cells previously unrecognized in the setting of vaccine induced protective immunity. For example, we uncovered two T&#x000a0;cell populations that express a strong type I interferon response signature (Tis), unexpected in the context of antifungal immunity, but consistent with descriptions of the novel Tis T&#x000a0;cell phenotype recently reported in this journal. Unique to our report, we observe increased abundance of Tis T&#x000a0;cells only during a protective immune response, together with the unconventional dependence of the Tis signature on IFN-&#x003b3; receptor. We also highlight a unique CD4<sup>+</sup>T cell population enriched in protection that bears many NK cell markers including <italic>Nkg7</italic>, of recent interest for its regulatory role in CD4<sup>+</sup>T cell activation and pathogen control. Finally, although we validate previously described Th1- and Th17-skewed responses after protective and nonprotective vaccination, respectively, we uncover features of Th1 and Th17 responses that reflects a tension between the widely accepted framework of conventional T helper cell archetypes (Th1, Th2, Th17) and the nuance that can be detected by newer, hypothesis-free approaches to immune cell profiling.</p></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>scRNAseq analysis of antigen-specific memory CD4<sup>+</sup>T cells from intranasally (IN) and subcutaneously (SC) vaccinated, <italic>Blastomyces</italic>-challenged mice</title><p id="p0065">Mice were vaccinated either intranasally (IN) or subcutaneously (SC) with <italic>Blastomyces dermatitidis</italic> endoglucanase-2 (Bl-Eng2) six weeks before pathogen challenge (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>A). As described previously, these routes of vaccine delivery both induce substantial numbers of antigen-specific T&#x000a0;cells but are associated with divergent outcomes in response to lethal experimental challenge with <italic>B.&#x000a0;dermatitidis</italic>. Mice vaccinated SC effectively control lung fungal burden, whereas mice vaccinated IN do not (<xref rid="bib8" ref-type="bibr">Dobson et&#x000a0;al., 2020</xref>). For scRNAseq analysis, tetramer-positive CD4<sup>+</sup>T cells were FACS sorted and sequenced 3&#x000a0;days after the pulmonary challenge with <italic>B.&#x000a0;dermatitidis</italic> (<xref rid="fig1" ref-type="fig">Figures&#x000a0;1</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>).<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Single-cell RNAseq analysis of tetramer-positive T&#x000a0;cells in <italic>Blastomyces-</italic>challenged mice following subcutaneous (SC) or intranasal (IN) vaccination</p><p>(A)Experimental schema for IN and SC vaccination with <italic>Blastomyces</italic> endoglucanase-2 (Bl-Eng2), lethal experimental challenge with <italic>Blastomyces</italic>, sorting of Bl-Eng2-specific CD4<sup>+</sup>T cells with tetramer, and single-cell RNAseq.</p><p>(B) Gating strategy for selection of tetramer<sup>+</sup> CD4<sup>+</sup>T cells. Representative flow cytometry plots shown for the SC group cells; see <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref> for IN group flow cytometry plots.</p><p>(C) Uniform manifold approximation and projection (UMAP) for integrated analysis of SC and IN group cells yields 16 distinct cell clusters. Cluster numbers are assigned based on largest population (cluster 1) to smallest (cluster 16).</p></caption><graphic xlink:href="gr1"/></fig></p><p id="p0070">Integrated analysis of tetramer-positive cells from the IN and SC groups yielded 16 distinct cell clusters numbered in order of decreasing size (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>C and <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S1</xref>). With exception of dividing populations described below, clusters contained cells across all stages of the cell cycle and were not affected by regression of cell cycle genes (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S1</xref>). All cell clusters expressed <italic>Cd3d</italic> (CD3), <italic>Cd4</italic> (CD4), and <italic>Trac</italic> (TCR&#x003b1; constant chain), consistent with the gating strategy to select for CD4<sup>+</sup>T cells (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>A). Most clusters also bore markers of tissue residence (T<sub>RM</sub>) such as <italic>Cd69</italic> (CD69), the galectins <italic>Lgals1</italic> and <italic>Lgals3</italic>, and <italic>Vim</italic> (vimentin) (<xref rid="fig2" ref-type="fig">Figures&#x000a0;2</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S2</xref>) (<xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>). Two populations (clusters 9, 16) specifically expressed <italic>Ccr7</italic> and <italic>Sell</italic>, markers of resting naive or T<sub>CM</sub>T cells that can be associated with lymphocyte transit to the site of infection (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>C) (<xref rid="bib7" ref-type="bibr">Debes et&#x000a0;al., 2005</xref>; <xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>). These findings indicate the expected presence of CD4<sup>+</sup> memory T&#x000a0;cells specific to the vaccine antigen with both tissue-resident and migratory phenotypes.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Identities of scRNAseq clusters</p><p>(A) Expression of CD4<sup>+</sup>T cell genes (<italic>Trac, Cd3d</italic>) is consistent with gating strategy at the protein level across all 16 clusters.</p><p>(B) UMAPs for T<sub>RM</sub> markers <italic>Cd69</italic>, <italic>Lgasl1</italic>, <italic>Lgals2</italic>, and <italic>Vim</italic> show nonspecific expression patterns across most clusters.</p><p>(C) UMAPs for resting (naive/T<sub>CM</sub>) markers <italic>Ccr7</italic> and <italic>Sell</italic> show expression localizing to clusters 9 and 16.</p><p>(D) Heatmap showing average expression and percent of cells expressing key genes to assign cluster identities. Marker genes include known lymphocyte marker genes and top differentially expressed genes identified as cluster markers by the scRNAseq package Seurat. Abbreviations: Tis T&#x000a0;= Type I interferon signature T&#x000a0;cells; NK-Th1&#x000a0;= NK-like Th1 cells; MyT&#x000a0;= myeloid-like T&#x000a0;cells.</p></caption><graphic xlink:href="gr2"/></fig></p></sec><sec id="sec2.2"><title>Cluster identities</title><p id="p0075">Specific cluster identities were further interrogated by a combination of known marker genes and cluster markers identified by scRNAseq differential expression analysis (<xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>D). The largest populations bore conventional Th1 and Th17 cell signatures: high expression of <italic>Ifng</italic> (IFN&#x003b3;) and Th1 transcription factor <italic>Tbx21</italic> (T-bet) (cluster 1); and high expression of <italic>Il17a</italic> (IL-17A), <italic>Il17f</italic> (IL-17F), <italic>Ccr6</italic>, and Th17 transcription factor <italic>Rorc</italic> (ROR&#x003b3;t) (cluster 2). Of interest, these clusters adjoined a spectrum of 5 additional populations also expressing Th1 genes, Th17 genes, or both (clusters 3&#x02013;7). In addition to their cytokine phenotype, these clusters were distinguished by expression of genes less familiar to the classic Th framework, including: <italic>Ctsw</italic> and <italic>Ctsd</italic> (cathepsins W and D; cluster 4); <italic>Vps37b</italic> (vacuolar protein sorting 37B) and <italic>Ramp3</italic> (receptor activity modifying protein 3) (cluster 6) (<xref rid="bib30" ref-type="bibr">Miragaia et&#x000a0;al., 2019</xref>); co-stimulatory signaling genes <italic>Tnfrsf4</italic> (OX40/CD134) and <italic>Tnfrsf9</italic> (4-1BBL/CD137) (cluster 7); <italic>Ramp1</italic> (receptor activity modifying protein 1; cluster 5); and activator protein subunit genes <italic>Jun</italic> and <italic>Fos</italic> (cluster 3).</p><p id="p0080">An unexpected and remarkable finding is that two populations (clusters 8, 13) expressed high levels of type I interferon response genes (<italic>Stat1, Isg15</italic>, <italic>Ifi206</italic>, <italic>Ifit3, Mx1</italic>). Although the type I interferon response is classically understood as an antiviral program, this type I interferon signature (Tis) has been described elsewhere outside of an antiviral immune context in CD4<sup>+</sup> T helper cells, Tregs, and thymic invariant natural killer T (iNKT) cells (<xref rid="bib1" ref-type="bibr">Andreatta et&#x000a0;al., 2021</xref>; <xref rid="bib2" ref-type="bibr">Arazi et&#x000a0;al., 2019</xref>; <xref rid="bib19" ref-type="bibr">Gowthaman et&#x000a0;al., 2019</xref>; <xref rid="bib21" ref-type="bibr">Harsha Krovi et&#x000a0;al., 2020</xref>; <xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>; <xref rid="bib42" ref-type="bibr">Seumois et&#x000a0;al., 2020</xref>; <xref rid="bib43" ref-type="bibr">Singhania et&#x000a0;al., 2019</xref>; <xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>; <xref rid="bib52" ref-type="bibr">Tibbitt et&#x000a0;al., 2019</xref>; <xref rid="bib54" ref-type="bibr">Zemmour et&#x000a0;al., 2020</xref>). Here, we adopt the term Tis T&#x000a0;cells to describe these distinct populations. We also observed a population (cluster 12) notable for very high expression of chemokine <italic>Ccl5</italic> (CCL5) and multiple NK-cell markers including <italic>Nkg7</italic> (natural killer granule protein 7), <italic>Klrd1</italic> (CD94), and <italic>Klrb1c</italic> (CD161). Because this cluster also expressed Th1 genes (<italic>Ifng</italic>, <italic>Tbx21</italic>) at a level comparable to a conventional Th1 phenotype (cluster 1), we provisionally termed this cluster NK-like Th1 cells.</p><p id="p0085">The remaining populations included Tregs (<italic>Foxp3, Ikzf2</italic>; cluster 15), two populations of dividing cells (<italic>Cdk1, Mki67, Tuba1b, Stmn1</italic>; clusters 14, 10), and naive/T<sub>CM</sub> cells (<italic>Ccr7, Sell</italic>; cluster 9) (<xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>). We also saw a population of transcriptionally less active cells (cluster 11) that expressed markers for prolonged survival (<italic>Bcl2, Cdk6</italic>), suggesting quiescent cells distinct from the resting naive/T<sub>CM</sub> population expressing <italic>Ccr7</italic> and <italic>Sell</italic> (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>) (<xref rid="bib6" ref-type="bibr">Cheng et&#x000a0;al., 2004</xref>). Lastly, we observed a very small population of cells bearing myeloid markers (<italic>H2-Ab1, Apoe, Lyz2</italic>; cluster 16). Since this smallest group of cells still expressed CD4<sup>+</sup>T cell markers and did not exhibit increased reads suggestive of myeloid cell-T cell doublets (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>), we tentatively labeled them myeloid-like T (MyT) cells, adopting the term for a population of &#x003b1;&#x003b2;T cells that acquire myeloid markers peripherally and have been validated elsewhere with flow cytometry and RNAseq (<xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>). Our ability to validate this novel cell type, however, was limited by the small number of cells for analysis (N&#x000a0;= 44, 0.2% all cells).</p></sec><sec id="sec2.3"><title>Differential abundance and gene expression between cells from IN and SC vaccinated mice</title><p id="p0090">The relative abundance of many clusters differed between the IN and SC groups (<xref rid="fig3" ref-type="fig">Figures&#x000a0;3</xref>A, 3B, and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>; <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S1</xref>). IN populations with increased relative abundance included <italic>Il17a</italic>-producing clusters (clusters 2, 6, 7), naive/T<sub>CM</sub> cells (cluster 9), one population of dividing cells (cluster 14), and Tregs (cluster 15). By contrast, SC populations with increased relative abundance included <italic>Ifng</italic>-expressing clusters (clusters 1, 4), Tis T&#x000a0;cells (clusters 8, 13), and NK-like Th1 cells (cluster 12). Unsurprisingly, the shift in relative abundance was associated with differential gene expression across all antigen-specific cells in the IN group compared to SC group (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C; <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S2</xref>). Average <italic>Il17a</italic> expression was higher for the IN group, consistent with a Th17-skewed response to pathogen challenge seen previously with this route of vaccination, as was expression of other intercellular signaling genes including <italic>Ccr6</italic> (CCR6) and <italic>Cxcr4</italic> (CXCR4) (<xref rid="bib8" ref-type="bibr">Dobson et&#x000a0;al., 2020</xref>). By contrast, the SC group showed higher average expression of <italic>Ifng</italic>, macrophage- and granulocyte/macrophage-stimulating genes <italic>Csf1</italic> (M-CSF) and <italic>Csf2</italic> (GM-CSF), the chemokine <italic>Ccl5</italic> (CCL5<italic>,</italic> aka RANTES), and chemokine receptor <italic>Cxcr6</italic> (CXCR6). This skewed Th17 response in the unprotected IN group was unexpected, since Th17 response is generally believed to promote protection against fungi at mucosal surfaces (<xref rid="bib23" ref-type="bibr">Huppler et&#x000a0;al., 2012</xref>).<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Differences in relative cluster abundance and gene expression between IN and SC vaccinated mice</p><p>(A) UMAP of 16 cell clusters separated by IN and SC sample origin, showing shifts in relative cluster abundance between these two groups.</p><p>(B) Scatterplot of relative proportions of each cluster within all IN group cells (x-axis) and SC group cells (y-axis). Clusters falling above dotted line have higher relative abundance for SC group; clusters below dotted line have higher relative abundance for IN group. Those with &#x0003e;2x increased relative abundance in IN or SC samples are green and purple, respectively; cluster 16 made up &#x0003c;1% of all cells and was not color coded.</p><p>(C) Dot plot of key genes with differential expression between IN and SC samples, grouped by functional similarity (colored annotation to the right of panel); all with exception of <italic>Lag3</italic> and <italic>Pdcd1</italic> are significantly different (p&#x0003c; 0.05). High and low activation gene lists are adapted from scRNAseq profiling of CD4<sup>+</sup>T cells elsewhere (see Kiner et&#x000a0;al., <italic>e.g.,</italic><xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>D.).</p><p>(D) UMAP for activation-induced immune chekpoint gene <italic>Ctla4</italic>. Circled clusters 4, 5 and 13 are shown in detail with the violin plot for <italic>Ctla4</italic> expression in (e), where these clusters show decreased expression SC compared to IN. This difference contrasts with stable <italic>Ctla4</italic> expression in Tregs in both IN and SC groups.</p><p>(F)UMAP for <italic>Il17a</italic> and <italic>Ifng</italic>, separated by IN and SC groups.</p><p>(G)Number of cells within each cluster expressing <italic>Il17a</italic> only, <italic>Ifng</italic> only, both <italic>Il17a</italic> and <italic>Ifng</italic>, or neither cytokine. Note the switch in dominant cytokine from <italic>Il17a</italic> to <italic>Ifng</italic> within certain clusters (e.g. cluster 3) depending on vaccine exposure route.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0095">Other salient differences included increased expression in the SC group of type I interferon response genes and NK cell markers, as would be expected with increased abundance of Tis T and NK-like Th1 cells. In the IN group, we also observed increased expression of some activation-related genes such as Jun and Fos family genes (<italic>Jun, Junb, Fos, Fosl2</italic>) and activation-induced immune checkpoint gene <italic>Ctla4</italic> (CTLA-4) (<xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>). Because high activation genes did not universally segregate to the IN group, nor low activation genes to the SC group, this data suggests complexity beyond the hypothesis that one vaccine route might prime a more activated CD4<sup>+</sup>T cell phenotype than the other route during pathogen challenge. Nevertheless, our data showed a trend toward increased expression of some exhaustion markers such as <italic>Ikzf2</italic> (Helios), <italic>Lag3</italic> (Lymphocyte activation gene 3), and <italic>Pdcd1</italic> (Programmed cell death 1 [Pd1]) (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>C). Although this difference did not correspond to marked differences between the IN and SC groups in the relative abundance of proliferating cells (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B), we did observe increased expression of activation-induced immune checkpoint gene <italic>Ctla4</italic> in the IN group, which was not exclusively explained by the increased abundance of Tregs, but rather appeared to reflect specific downregulation of this critical checkpoint gene in non-Treg clusters in the SC group (<xref rid="fig3" ref-type="fig">Figures&#x000a0;3</xref>D and 3E). This data may suggest greater activation-induced exhaustion in the IN group, or perhaps escape from this negative feedback mechanism in the protective vaccine-induced immune response.</p></sec><sec id="sec2.4"><title>Analysis of Th1 and Th17 phenotypes</title><p id="p0100">We next analyzed characteristic Th1 and Th17 cytokine gene expression at the single cell level. Of interest, the Th17 cytokine phenotype in the IN group reflected not only the relative expansion of populations characterized by <italic>Il17a</italic> expression regardless of vaccination route (e.g. cluster 2), but also from an increased <italic>Il17a</italic> expression within populations that would otherwise express <italic>Ifng</italic> in mice vaccinated SC (e.g. cluster 3) (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>F). Similarly, the Th1 cytokine phenotype in the SC group appeared associated with increased abundance of populations restricted to <italic>Ifng</italic> expression (e.g. clusters 1, 4) as well as a switch from <italic>Il17a</italic> to <italic>Ifng</italic> dominance in other Th1/Th17 populations. The distribution of Th1 and Th17 transcription factors <italic>Tbx21</italic> (Tbet) and <italic>Rorc</italic> (ROR&#x003b3;t) mirrored the patterns seen in downstream cytokine expression (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>). This fluidity of the dominant cytokine phenotypes in Th1/Th17 cells complicates assignments of strict Th archetypes and may align with evolving notions of Th cell cytokine plasticity, for instance in Th17 cells described elsewhere (<xref rid="bib58" ref-type="bibr">Zhu and Paul, 2010</xref>). Alternatively, this result may indicate dual cytokine production among cells from each vaccine group. There were stable small fractions of cells producing both cytokines simultaneously (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>F), though the limited sequencing depth for each cell in scRNAseq makes it challenging to differentiate whether these subpopulations are a true minority or simply undersampled.</p></sec><sec id="sec2.5"><title>TCR gene usage</title><p id="p0105">We explored whether cytokine phenotypes reflected the presence of a few expanded, highly active T&#x000a0;cell clones, or a broader diversity of T&#x000a0;cells responding to pathogen challenge. Using TRUST4, an algorithm that infers TCR clonotypes using focused reconstruction of variable TCR gene regions (<xref rid="bib45" ref-type="bibr">Song et&#x000a0;al., 2021</xref>), we recovered sufficient TCR sequence data from all 16 clusters to assign clonotypes by &#x003b1;, &#x003b2;, or combined &#x003b1;&#x003b2; TCR sequences to 2,421 and 2,619 T&#x000a0;cells in the IN and SC samples, respectively (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S3</xref>). Especially for &#x003b1; and &#x003b1;&#x003b2; chains, we observed that clonotypes tended to be skewed in distribution between the IN and SC groups, with individual clonotypes occurring predominantly in either one or the other group (<xref rid="fig4" ref-type="fig">Figure&#x000a0;4</xref>A). The IN group showed dominance of relatively few clonotypes, whereas the SC group exhibited more even representation of clonotypes comprising at least 2% of either sample (<xref rid="fig4" ref-type="fig">Figures&#x000a0;4</xref>B and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>). In both groups, the most frequent clonotypes were most abundant in the largest clusters expressing high levels of Th1 and Th17 cytokines (<italic>e.g</italic>., clusters 1&#x02013;7; <xref rid="fig4" ref-type="fig">Figures&#x000a0;4</xref>C and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>). Thus, the size of these clusters appeared to reflect expanded, active T&#x000a0;cell clones, with many TCR sequences unique to either the IN or SC group.<fig id="fig4"><label>Figure&#x000a0;4</label><caption><p>TCR clonotype diversity in IN and SC vaccinated mice</p><p>(A) Relative abundance of TCR &#x003b1;, &#x003b2;, and &#x003b1;&#x003b2; chain clonotypes identified by TRUST4 in IN and SC samples.</p><p>(B)TCR &#x003b1;-chain clonotypes vary in relative abundance between IN and SC samples. Only clonotypes with &#x0003e;2% abundance in either sample are shown.</p><p>(C) Distribution of the top 5 TCR &#x003b1;-chain clonotypes across each cluster. The size of each circle depicts the number of cells expressing each clonotype per cluster. The color represents how relatively enriched (red) or depleted (blue) that cluster is for a given clonotype. White color indicates that the frequency of the clonotype is the same as the frequency across the entire sample.</p></caption><graphic xlink:href="gr4"/></fig></p></sec><sec id="sec2.6"><title>Special populations in nonprotective immune response: Tregs</title><p id="p0110">We noted the higher relative abundance of <italic>Foxp3</italic>-expressing Tregs in the nonprotective IN vaccine-induced immune response (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>A), consistent with prior experimental data in this model (<xref rid="bib8" ref-type="bibr">Dobson et&#x000a0;al., 2020</xref>). Because mucosal antigen exposure can induce systemic immune tolerance, we wondered whether these Tregs might be impairing pathogen clearance by actively suppressing antifungal immunity (<xref rid="bib39" ref-type="bibr">Rezende and Weiner, 2017</xref>). Tregs in the IN group, however, did not express high levels of tolerogenic cytokine genes such as <italic>Tgfb1</italic> (transforming growth factor &#x003b2;), <italic>Il10</italic> (interleukin-10), or <italic>Il4</italic> (interleukin-4) (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>B). Nor did we observe increased expression of markers of T&#x000a0;cell anergy (e.g. <italic>Rnf128</italic> [GRAIL]) to suggest other mechanisms of tolerance in cells of the IN group (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>). Indeed, other observed features of the response to pathogen challenge in the IN group, including prominent <italic>Il17a</italic> expression, appeared more consistent with pro-inflammatory response to a lethal pathogen than with microbial tolerance.<fig id="fig5"><label>Figure&#x000a0;5</label><caption><p>Tregs and NK-like Th1 cells in IN and SC vaccinated mice</p><p>(A) Relative abundance of Tregs in IN and SC samples, expressed as percent of total cells in each sample.</p><p>(B) Violin plot showing average expression of tolerogenic Treg cytokines <italic>Tgfb1</italic> (TGF&#x003b2;), <italic>Il10</italic> (IL-10), and <italic>Il4</italic> (IL-4), IN compared to SC.</p><p>(C) Relative abundance of cluster 12 cells (NK-like Th1) in IN and SC samples, expressed as percent of total cells in each sample.</p><p>(D) UMAP for <italic>Nkg7</italic>, an NK marker highly expressed in multiple SC-enriched populations including cluster 12.</p><p>(E) UMAP for chemokine <italic>Ccl5</italic>, showing focal expression by cluster 12 cells.</p><p>(F) Heatmap of average cluster expression of NKT1 marker genes identified in thymic Cd1d tetramer-positive cells (see: Engel et&#x000a0;al., <xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>). (<xref rid="bib12" ref-type="bibr">Engel et&#x000a0;al., 2016</xref>) Markers are primarily upregulated in NKT1 cells but include a subset of 4 genes downregulated in NKT1 (<italic>Atpif1, Ckb, Rexo2, Emb</italic>).</p></caption><graphic xlink:href="gr5"/></fig></p></sec><sec id="sec2.7"><title>Special populations in protective immune response: NK-like Th1 cells</title><p id="p0115">We explored whether populations specific to the SC group might explain the distinctive efficacy of this vaccine immune response. One such population was the NK-like Th1 cells (cluster 12), for which a gene set enrichment analysis of its expression profile relative to cells from all other clusters resulted in the NK cell type as the most significantly enriched mouse cell type signature (adjusted pvalue&#x000a0;&#x0003c;&#x000a0;3 x10<sup>&#x02212;9</sup>). This cluster was distinct for high levels of NK markers such as <italic>Nkg7</italic> (natural killer granule protein 7), <italic>Klrb1c</italic> (CD161), and <italic>Klrd1</italic> (CD94) (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>C). Among these markers, <italic>Nkg7</italic> raised particular interest because of an emerging role for inducible <italic>Nkg7</italic> in CD4<sup>+</sup>T cells, where it appears to be associated with IFN&#x003b3; expression and promote parasite control in a model of <italic>Leishmania donovani</italic> infection (<xref rid="bib34" ref-type="bibr">Ng et&#x000a0;al., 2020</xref>). Indeed, we observed increased <italic>Nkg7</italic> expression in those populations enriched in the SC group&#x02019;s <italic>Ifng-</italic>polarized immune response, including in the highest <italic>Ifng</italic>-expressing populations (clusters 1, 4, 3), Tis T&#x000a0;cells (clusters 13, 8), and NK-like Th1 cells (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>D). These NK-like Th1 cells were also notable for specific expression of the gene <italic>Ccl5</italic> (CCL5 or RANTES), a pleiotropic chemokine that attracts effector and memory cells to the site of infection and is unique among CC-type chemokines for its role in the later stages of response to infection (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>E) (<xref rid="bib35" ref-type="bibr">Ortiz et&#x000a0;al., 1996</xref>). Notably, although NK markers such as granzyme (<italic>Gzmb</italic>) and perforin (<italic>Prf1</italic>) are associated with cytotoxic function, our NK-like Th1 cells did not express markers of cytotoxic CD4<sup>+</sup>T cells, a recently described population that appears capable of inducing apoptosis of target cells in an MHC class II-restricted manner (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>) (<xref rid="bib50" ref-type="bibr">Takeuchi and Saito, 2017</xref>).</p><p id="p0120">Based on NK markers, we considered whether these cells might be NKT cells, an innate-like T&#x000a0;cell population that expresses &#x003b1;&#x003b2;TCR and combines NK cell reactivity with some of the antigen-specificity of T&#x000a0;cells (<xref rid="bib18" ref-type="bibr">Godfrey et&#x000a0;al., 2004</xref>). Indeed, cluster 12 cells expressed many of the genes up- and down-regulated in Th1-like NKT cells (NKT1) by scRNAseq profiling (<xref rid="fig5" ref-type="fig">Figure&#x000a0;5</xref>F) (<xref rid="bib12" ref-type="bibr">Engel et&#x000a0;al., 2016</xref>). Importantly, however, these cells lacked expression of the gene for PZLF (<italic>Zbtb16</italic>), a transcription factor marker for most innate and innate-like T&#x000a0;cell populations including NKT cells (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S4</xref>) (<xref rid="bib27" ref-type="bibr">Mao et&#x000a0;al., 2017</xref>). Moreover, the TCR of NKT cells classically binds Cd1d, an MHC class I-type receptor that presents lipid antigen, and would not be expected to bind the MHC class II tetramer and peptide antigen used to sort our Bl-Eng2-specific T&#x000a0;cells. Although some have reported NKT cells in CD1d-deficient mice&#x02014;including CCL5 producers as seen here&#x02014;others insist on CD1d-restriction as an essential feature for the term NKT to remain meaningful (<xref rid="bib10" ref-type="bibr">Eberl et&#x000a0;al., 1999</xref>; <xref rid="bib14" ref-type="bibr">Farr et&#x000a0;al., 2014</xref>; <xref rid="bib17" ref-type="bibr">Giroux and Denis, 2005</xref>; <xref rid="bib18" ref-type="bibr">Godfrey et&#x000a0;al., 2004</xref>). We opted for the term NK-like Th1 cells, emphasizing core Th1 features with additional NK marker expression. In either case, the appearance of this NK-like Th1 phenotype and the accompanying chemokine activity were salient, previously undescribed features of vaccine-induced protective immunity to fungi.</p></sec><sec id="sec2.8"><title>Special populations in the protective immune response: Tis T&#x000a0;cells</title><p id="p0125">Tis (type I interferon signature) T&#x000a0;cells (clusters 8, 13) were another cell phenotype associated with the protective immune response. Especially in the SC group, these cells comprised a meaningful portion of our tetramer positive T&#x000a0;cells, representing 12.6 and 4.2% of all cells in the SC and IN vaccine groups, respectively (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>A). These populations showed a transcriptional signature dominated by several type I interferon-responsive genes (<italic>Ifitm3, Ifi204, Isg15</italic>, <italic>Isg20</italic>, <italic>Mx1</italic>, <italic>Rsad2</italic>, <italic>Oas3</italic>, etc.) (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>B). This signature included genes upstream in type I interferon signal transduction, such as <italic>Stat1</italic> (Stat1) and <italic>Stat2</italic> (Stat2), and those associated with distal interferon response functions such as global suppression of translation (<italic>e.g., Eif2ak2</italic> [EIF2&#x003b1; kinase 2]), processing of cytosolic DNA and RNA (e.g. <italic>Ddx58</italic> [RIG-I], <italic>Zbp1</italic> [Z-DNA binding protein 1], and <italic>Samhd1</italic> [SAM and HD domain 1]), and protection from viral infections including influenza and SARS-CoV-2 (<italic>Ifitm3</italic> [interferon-induced transmembrane protein 3]) (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C and <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S3</xref>) (<xref rid="bib13" ref-type="bibr">Everitt et&#x000a0;al., 2012</xref>; <xref rid="bib38" ref-type="bibr">Prelli Bozzo et&#x000a0;al., 2021</xref>). Other Tis T&#x000a0;cell genes coding for transmembrane proteins (<italic>Rtp4</italic>, <italic>Bst2</italic> [tetherin/CD317]) and nuclear body proteins (<italic>Pml</italic>, <italic>Sp100</italic>) were noteworthy as potential cell surface or microstructural markers.<fig id="fig6"><label>Figure&#x000a0;6</label><caption><p>Tis T&#x000a0;cellphenotypes in IN and SC vaccinated mice</p><p>(A) Relative abundance of Tis T&#x000a0;cells in IN and SC samples, expressed as percent of total cells in each sample.</p><p>(B) UMAP for expression of type I interferon response genes, localizing Tis T&#x000a0;cells to clusters 8 and 13.</p><p>(C) Heatmap showing average expression and percent of cells expressing Tis T&#x000a0;cell markers noted in the literature (<italic>e.g. Isg15, Isg20, Mx1, Rsad2, Oas3, Ifit1, Ifit3</italic>) and identified as markers for both clusters by scRNAseq differential expression analysis.</p><p>(D) Heatmap for genes differing between the two clusters of Tis T&#x000a0;cells. Red and blue side bars represent those genes that are upregulated or downregulated in the first principal component (PC1) of CD4<sup>+</sup>T cells harvested after infection with pathogens including <italic>Salmonella typhimurium</italic>, <italic>Citrobacter rodentium</italic>, <italic>Heligmosomoides polygyrus</italic> and <italic>Nippostrongylus brasilensis</italic>; see Kiner, <xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S2</xref>) (<xref rid="bib24" ref-type="bibr">Kiner, 2019</xref>).</p><p>(E) UMAP showing similar patterns in activation gene expression, represented by <italic>Bhlhe40</italic> and <italic>Nfkbia,</italic> between cluster 13 Tis T&#x000a0;cells and nearby clusters 4 and 5, both IN and SC.</p></caption><graphic xlink:href="gr6"/></fig></p></sec><sec id="sec2.9"><title>Tis T&#x000a0;cell heterogeneity</title><p id="p0130">Tis T&#x000a0;cells separated into 2 clusters that shared a common strong type I interferon signature (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>C). However, one Tis T&#x000a0;cell population (cluster 8) distinctly expressed more <italic>Bhlhe40</italic> (basic-helix-loop-helix family member e40), a key transcription factor that characterizes a highly pro-inflammatory phenotype in CD4<sup>+</sup> memory T&#x000a0;cells (<xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>D and <xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S4</xref>) (<xref rid="bib11" ref-type="bibr">Emming et&#x000a0;al., 2020</xref>). This same Tis T&#x000a0;cell cluster also expressed higher levels of NF-&#x003ba;B inhibitors <italic>Nfkbia</italic> (I&#x003ba;B&#x003b1;)<italic>, Nfkbid</italic> (I&#x003ba;BNS)<italic>,</italic> and <italic>Nfkbiz</italic> (I&#x003ba;B&#x003b6;) (<xref rid="bib11" ref-type="bibr">Emming et&#x000a0;al., 2020</xref>), activator protein 1 (AP-1) subunit genes <italic>Junb</italic> (Junb) and <italic>Fosl2</italic> (Fra2), histone and histone modulating genes (e.g. <italic>H3f3b</italic> [H3.3 histone B], <italic>Kdm6b</italic> [lysine demethylase 6B]), and <italic>Zc3h12a</italic> (MCPIP1 or regnase-1) (<xref rid="bib16" ref-type="bibr">Garg et&#x000a0;al., 2015</xref>; <xref rid="bib28" ref-type="bibr">Matsushita et&#x000a0;al., 2009</xref>). Remarkably, many of these same markers have appeared recently in another scRNAseq analysis of CD4<sup>+</sup>T cell heterogeneity, in which transcriptional diversity was driven primarily by activation state rather than by conventional Th archetype as might have been expected (<xref rid="bib24" ref-type="bibr">Kiner, 2019</xref>; <xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>). In that analysis, activation-related genes (<italic>e.g., Bhlhe40, Jund, Dusp1, Btg1, Odc1, Vps37b</italic>) comprised the first principal component (PC1) driving transcriptional diversity in CD4<sup>+</sup>T cells following a variety of enteric infections (<xref rid="bib24" ref-type="bibr">Kiner, 2019</xref>). In querying our data for these PC1 genes, we saw that differing expression not only separated our Tis T&#x000a0;cell populations, but also organized non-Tis T&#x000a0;cells into two rough superclusters, in which Th1/Th17 clusters 4 and 5 grouped with cluster 13 Tis T&#x000a0;cells apart from surrounding Tis and non-Tis T&#x000a0;cells (<italic>e.g., Bhlhe40</italic>, <italic>Nfkbia</italic>; <xref rid="fig6" ref-type="fig">Figure&#x000a0;6</xref>E). This finding emphasized the importance of activation state as an organizing principle for CD4<sup>+</sup>T cell heterogeneity, including within Tis T&#x000a0;cells.</p><p id="p0135">We considered whether the separation of Tis T&#x000a0;cells into two populations (clusters 8 and 13) might reflect a sequence of cell differentiation, in which one phenotype might be a precursor to the other. These transitional patterns can be explored in scRNAseq with RNA velocity analysis. The ratio of unspliced and spliced reads mapping to a given gene is compared to expected steady state kinetics to make a prediction about an increase in transcription rate (with the resulting increase in unspliced mRNA) or vice versa (<xref rid="bib26" ref-type="bibr">La Manno et&#x000a0;al., 2018</xref>). In our Tis T&#x000a0;cells, however, we did not observe any genes characterizing the expression profile of one cluster among the genes with most significantly different velocity in the other (<xref rid="mmc1" ref-type="supplementary-material">Table&#x000a0;S5</xref>). This finding suggests that one population is not a precursor of the other population.</p></sec><sec id="sec2.10"><title>Validation of tis T&#x000a0;cell phenotype</title><p id="p0140">We validated the presence of the Tis T&#x000a0;cell phenotype by quantitative RT-PCR in vaccinated mice after <italic>Blastomyces</italic> challenge. Consistent with scRNAseq data, we detected a transcriptional signal for multiple Tis T&#x000a0;cell marker genes (<italic>Ifi204</italic>, <italic>Mx1</italic>, <italic>Pml</italic>, <italic>Slfn5</italic>, <italic>Ifit1</italic>, <italic>Ifitm3</italic>) present among tetramer<sup>+</sup> antigen-specific CD44<sup>+</sup> cells, but not among control (CD44<sup>&#x02212;</sup>) cells, in both the lung and spleen after pulmonary pathogen challenge (<xref rid="fig7" ref-type="fig">Figures&#x000a0;7</xref>A and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>). This difference in expression was distinct from the upregulation of interferon response genes in both antigen-specific and control cells following exposure to soluble type I interferon (IFN&#x003b1;), though the relative enrichment of several Tis T&#x000a0;cell transcripts in antigen-specific cells relative to control cells was still detectable in this experiment. As expected, relative expression of Tis T&#x000a0;cell markers <italic>Ifi204</italic> and <italic>Ifitm3</italic> was increased in tetramer-positive T&#x000a0;cells from SC vaccinated animals compared to those from the IN group (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>B), conforming to results from our scRNAseq analysis (<xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>B).<fig id="fig7"><label>Figure&#x000a0;7</label><caption><p>RT-PCR Tis T&#x000a0;cellsignature</p><p>(A) Quantitative reverse transcriptase PCR (RT-qPCR) detects increased expression of Tis T&#x000a0;cell marker genes (<italic>Ifi204, Mx1, Pml, Slfn5, Ifit1, Ifitm3</italic>) in tetramer-positive, CD44-positive (black) cells compared to control CD44-negative (white) cells from the lungs of <italic>Blastomyces</italic>-challenged, subcutaneously vaccinated mice. The addition of IFN&#x003b1; increased expression of these genes in both tetramer-positive and control cells.</p><p>(B) Tis T&#x000a0;cell signature (<italic>Ifi204</italic>, <italic>Ifitm3</italic>) was increased in SC vaccinated animals compared to IN vaccinated animals by RT-qPCR.</p><p>(C) Violin plot depicting expression of interferon receptor genes in Tis T&#x000a0;cells (clusters 8, 13). Although these clusters expressed the IFN&#x003b3;R &#x003b1;-chain, the corresponding &#x003b2;-chain was not detected.</p><p>(D) Tis T&#x000a0;cell signature is diminished in lungs of <italic>Blastomyces</italic>-challenged, subcutaneously vaccinated mice lacking IFN&#x003b3;R (IFN&#x003b3;R-KO) as compared to wild type mice. For panels a, b, and d: &#x02217;, p&#x0003c;0.05; &#x02217;&#x02217;p&#x0003c;0.01; &#x02217;&#x02217;&#x02217;, p&#x0003c;0.001. Analysis by Student&#x02019;s <italic>t</italic> test. Data are from one representative experiment of three performed (mean&#x000a0;&#x000b1; SD of three biological replicates).</p></caption><graphic xlink:href="gr7"/></fig></p></sec><sec id="sec2.11"><title>IFN&#x003b3;R-dependence of tis T&#x000a0;cell signal</title><p id="p0145">We sought to understand upstream signaling for the Tis T&#x000a0;cell signature. Remarkably, despite an increased and highly specific type I interferon gene signature, our Tis T&#x000a0;cell populations did not express the type I interferon receptor genes <italic>Ifnar1</italic> (IFNAR1) and <italic>Ifnar2</italic> (IFNAR2) (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>C) (<xref rid="bib52" ref-type="bibr">Tibbitt et&#x000a0;al., 2019</xref>). Other investigators studying <italic>T.&#x000a0;gondii</italic>-infected mice have described a strong type I IFN transcription module dependent on the presence of IFN&#x003b3;R, another type II cytokine receptor (<xref rid="bib43" ref-type="bibr">Singhania et&#x000a0;al., 2019</xref>). We hypothesized that this transcription module might reflect the presence of Tis T&#x000a0;cells and tested whether our Tis T&#x000a0;cell signature may similarly depend on IFN&#x003b3;R. To explore this idea, we vaccinated IFN&#x003b3;R<sup>&#x02212;/&#x02212;</sup> (IFN&#x003b3;R KO) mice SC. We found that, after pulmonary challenge, the presence of signature transcripts for Tis T&#x000a0;cells was diminished in tetramer<sup>+</sup> antigen-specific T&#x000a0;cells, but not in CD44<sup>&#x02212;</sup> control cells (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>D). Thus, the emergence of Tis T&#x000a0;cells requires IFNgR signaling. In contrast to the Tis T&#x000a0;cell transcripts, the relative expression of <italic>Il17a</italic> was increased in IFN&#x003b3;R KO mice, suggesting a compensatory effect in the dynamic balance between Th1 and Th17 cytokine environments.</p><p id="p0150">Intriguingly, although scRNAseq data did show that Tis T&#x000a0;cells express IFN&#x003b3;R &#x003b1;-chain gene (<italic>Ifngr1</italic>), these cells did not express the IFN&#x003b3;R &#x003b2;-chain gene (<italic>Ifngr2</italic>) presumed to confer IFN&#x003b3; responsiveness to T&#x000a0;cells (<xref rid="fig7" ref-type="fig">Figure&#x000a0;7</xref>E) (<xref rid="bib4" ref-type="bibr">Bach et&#x000a0;al., 1995</xref>, <xref rid="bib3" ref-type="bibr">1997</xref>). Moreover, soluble IFN&#x003b3; did not elicit any upregulation of the Tis T&#x000a0;cell signature genes in tetramer positive cells in our RT-PCR experiments (<xref rid="mmc1" ref-type="supplementary-material">Figure&#x000a0;S5</xref>). Together, this data suggests the dependence of the Tis T&#x000a0;cell signature on IFN&#x003b3;R, apparently by a mechanism distinct from classic IFN&#x003b3;-IFN&#x003b3;R receptor signaling.</p></sec></sec><sec id="sec3"><title>Discussion</title><p id="p0155">Antigen-specific T&#x000a0;cells are essential for vaccine-induced immunological memory and effective pathogen control. Our work demonstrates key differences in the phenotypic profiles of antigen-specific CD4<sup>+</sup>T cells&#x000a0;present at the site of pathogen challenge in a protective and nonprotective vaccine model. Our study yields some distinctly surprising results in addition to expected findings. We observe unique cell populations, including two with high expression of type I interferon signature genes and one highly expressing <italic>Ccl5</italic> that are associated specifically with protective vaccine-induced immunity. We also redemonstrate essential differences in Th1- and Th17-skewing of protective and nonprotective vaccine-induced responses, reflecting the activity of conventional appearing, clonally dominant Th1 and Th17 cells together with a spectrum of more phenotypically heterogeneous <italic>Ifng</italic>- and <italic>Il17a</italic>-expressing populations.</p><p id="p0160">We uncovered a Tis T&#x000a0;cell phenotype enriched among antigen-specific cells that confer vaccine-induced immunity. We did not expect to see type I interferon signaling in the context of vaccine-primed responses to <italic>B.&#x000a0;dermatitidis</italic>, a fungal pathogen traditionally understood to elicit Th1- and Th17-related cytokines such as IFN-&#x003b3;, TNF-a, IL-17, and IL-6 (<xref rid="bib29" ref-type="bibr">Merkhofer et&#x000a0;al., 2019</xref>; <xref rid="bib46" ref-type="bibr">Speakman et&#x000a0;al., 2020</xref>). Others have recently observed Tis T&#x000a0;cells in settings outside of viral infection (<xref rid="bib1" ref-type="bibr">Andreatta et&#x000a0;al., 2021</xref>; <xref rid="bib2" ref-type="bibr">Arazi et&#x000a0;al., 2019</xref>; <xref rid="bib19" ref-type="bibr">Gowthaman et&#x000a0;al., 2019</xref>; <xref rid="bib21" ref-type="bibr">Harsha Krovi et&#x000a0;al., 2020</xref>; <xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>; <xref rid="bib42" ref-type="bibr">Seumois et&#x000a0;al., 2020</xref>; <xref rid="bib43" ref-type="bibr">Singhania et&#x000a0;al., 2019</xref>; <xref rid="bib49" ref-type="bibr">Szabo et&#x000a0;al., 2019</xref>; <xref rid="bib52" ref-type="bibr">Tibbitt et&#x000a0;al., 2019</xref>; <xref rid="bib54" ref-type="bibr">Zemmour et&#x000a0;al., 2020</xref>). However, our findings&#x02014;validated by RT-qPCR&#x02014;add new insight to this enigmatic, recently described population of T&#x000a0;cells. In our model, Tis T&#x000a0;cells were associated with a protective, vaccine-induced immune response. We also observed phenotypic heterogeneity underlying the Tis T&#x000a0;cell signature that has not been previously described, including divergent expression of the pro-inflammatory transcription factor <italic>Bhlhe40</italic> and other activation-related genes that appear to be an organizing framework for CD4<sup>+</sup>T cells across microbially diverse infectious challenges (<xref rid="bib11" ref-type="bibr">Emming et&#x000a0;al., 2020</xref>; <xref rid="bib25" ref-type="bibr">Kiner et&#x000a0;al., 2021</xref>). The loss of the Tis T&#x000a0;cell signature in IFN&#x003b3;R KO mice is another remarkable feature that merits future study. We wonder whether the IFN&#x003b3;R &#x003b1;-chain expressed nonspecifically in Tis T&#x000a0;cells could bind another unidentified cytokine receptor chain required for a novel type I IFN signature response, analogous to the combinatorial plasticity seen in other cytokine signaling mechanisms (<xref rid="bib32" ref-type="bibr">Morris et&#x000a0;al., 2018</xref>). Alternatively, the loss of IFN&#x003b3;R could indirectly mute the Tis T&#x000a0;cell response, e.g. through decreased T&#x000a0;cell activation in IFN&#x003b3;R KO mice overall. These hypotheses and other features of Tis T&#x000a0;cell biology, such as the possible antagonism of Tis T&#x000a0;cells by Th17 cells within the IN group, are exciting avenues for future functional studies.</p><p id="p0165">Our findings highlight the difficulties of classifying populations in scRNAseq that share features with multiple conventionally defined cell types, which are often described by only a few markers. In our data, NK-like Th1 cells make up one such population that resists straightforward identification based on overlapping features with Th1, NK, and NKT cells. Nonetheless, this ambiguity will be important to pursue. This population is a distinct feature of a protective vaccine-induced immune response in our model and the sole source of <italic>Ccl5</italic> expression. CCL5 is known to be unique among CC chemokines as a late-appearing signal, expressed three to five days after T&#x000a0;cell activation, with a role in attracting effector T&#x000a0;cells and new memory T&#x000a0;cells to the site of infection (<xref rid="bib35" ref-type="bibr">Ortiz et&#x000a0;al., 1996</xref>; <xref rid="bib41" ref-type="bibr">Seo et&#x000a0;al., 2020</xref>). The high expression of <italic>Ccl5</italic> three days after pathogen challenge in only the SC vaccine group might reflect a mechanism of improved pathogen clearance by early cytokine production and effector cell recruitment following protective vaccination. These cells also highly express <italic>Nkg7</italic>, a feature shared with other <italic>Ifng</italic>-expressing populations in the SC vaccinated group. The potential association between <italic>Nkg7</italic> expression and IFN&#x003b3; activity aligns with new data linking <italic>Nkg7</italic> and CD4<sup>+</sup>T cell activation and suggests a role for this molecule in regulating key effector cytokines from CD4<sup>+</sup>T cells in a protective vaccine-induced immune response (<xref rid="bib34" ref-type="bibr">Ng et&#x000a0;al., 2020</xref>).</p><p id="p0170">Lastly, our analysis confirms the core distinction between IFN&#x003b3;- and IL-17-skewed responses in protective and nonprotective vaccine-induced immune responses, respectively (<xref rid="bib8" ref-type="bibr">Dobson et&#x000a0;al., 2020</xref>). Notably, the highest cytokine producing, clonally dominant Th1 and Th17 cells that express archetypical Th markers lie at the extremes of a spectrum of phenotypes that differ by expression of genes that are distinctly unfamiliar to a classic Th paradigm. For instance, among the 29 immune cell types of the Monaco dataset shared in the Human Protein Atlas, the cluster 7 marker <italic>Rgs16</italic> appears more specific to B cells than either Th1 or Th17 cells, and cluster 3 marker <italic>Dnajb1</italic> is similarly expressed in Th1, Th2, and Th17 cells (<xref rid="bib31" ref-type="bibr">Monaco et&#x000a0;al., 2019</xref>; <xref rid="bib51" ref-type="bibr">The Human Protein Atlas, 2019</xref>). This reflects a tension between the widely accepted framework of conventional T helper cell archetypes (Th1, Th2, and Th17) and the nuance that can be detected by newer, hypothesis-free approaches to immune cell profiling. More work remains to discern whether this heterogeneity is functionally meaningful&#x02014;and if so, how it should be integrated into an organizing principle that remains useful for understanding immune cell ontogeny. Of note, these <italic>Ifng</italic>- and <italic>Il17a</italic>-expressing cell populations also appear to comprise largely non-overlapping TCR clonotypes, which might reflect either the stochastic effects of random V(D)J recombination before TCR selection by vaccination and pathogen challenge, some more active enrichment of specific TCR sequences within the protective immune response, or a combination of both.</p><sec id="sec3.1"><title>Limitations of the study</title><p id="p0175">Overall, our high-resolution single cell analysis of antigen-specific T&#x000a0;cells in pathogen challenge provides insight into multiple dimensions of vaccine-related T&#x000a0;cell biology. A general limitation of scRNAseq data is depth of sequencing, which comes at the cost of sequencing large numbers of cells (<xref rid="bib56" ref-type="bibr">Zhang et&#x000a0;al., 2020</xref>). More reads (<italic>e.g.</italic> greater depth) significantly reduces inaccuracy in estimating the true transcriptional state of a cell, but sequencing of more cells enables a broader view of the biological variability in the cell population. Consequently, we recognize that the absence of certain sequences does not exclude low level expression that was undetectable in our analysis. Other limitations inherent to study design include the lack of transcriptional data for antigen-nonspecific cells and of functional data for populations identified by scRNAseq. Thus, one should not assume causal relationships from the observed associations between cell phenotypes (<italic>e.g.,</italic> Tis T&#x000a0;cells, NK-like Th1 cells) and biological outcomes such as improved pathogen control following SC vaccination. Future studies are required to discern whether Tis T&#x000a0;cells, CCL5, or NKG7 are required for protective vaccine-induced immunity or are simply markers of this response that is driven by other cellular events. Our analysis of TCR sequences is also limited by use of conventional 3&#x02032; library preparation, which provides less coverage of hypervariable regions clustered toward the 5&#x02032; end and may be reason for choosing 5&#x02032; chemistry for more robust TCR analyses and clonotype tracking in the future. Nonetheless, our work describes novel characteristics of vaccine-induced T&#x000a0;cells in protective immunity, including populations that could serve as correlates of efficacy in vaccine design, and adds to the ongoing, exciting scientific pursuit of T&#x000a0;cell diversity.</p></sec></sec><sec id="sec4"><title>STAR&#x02605;Methods</title><sec id="sec4.1"><title>Key resources table</title><p id="p0180">
<table-wrap position="float" id="undtbl1"><table frame="hsides" rules="groups"><thead><tr><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr><td colspan="3"><bold>Antibodies</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>B220 APC</td><td>Biolegend</td><td>Cat#103211</td></tr><tr><td>CD11b APC</td><td>Biolegend</td><td>Cat#101211</td></tr><tr><td>CD11c APC</td><td>Biolegend</td><td>Cat#117309</td></tr><tr><td>CD16/CD32 (Mouse BD Fc Block&#x02122;)</td><td>BD</td><td>Cat#553142</td></tr><tr><td>CD4 BUV737</td><td>BD</td><td>Cat#612844</td></tr><tr><td>CD44 BV785</td><td>Biolegend</td><td>Cat#103059</td></tr><tr><td>CD8a PerCP-Cy5.5</td><td>Biolegend</td><td>Cat#100733</td></tr><tr><td>CD90.2 BV421</td><td>Biolegend</td><td>Cat#140327</td></tr><tr><td>NK1.1 APC</td><td>Biolegend</td><td>Cat#108709</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Bacterial and virus strains</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td><italic>Blastomyces dermatitidis</italic> (strain SCB2)</td><td>ATCC</td><td>ATCC 26199</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Chemicals, peptides, and recombinant proteins</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>ACK Lysing Buffer</td><td>ThermoFisher Scientific</td><td>Cat#A1049201</td></tr><tr><td>Albumin fraction V (from bovine blood)</td><td>Chem-Impex</td><td>Cat#00039</td></tr><tr><td>Bl-Eng2 Tetramer PE</td><td>NIH Tetramer Core Facility</td><td>N/A</td></tr><tr><td>Collagenase D</td><td>Roche</td><td>Cat#11088882001</td></tr><tr><td>Counting beads</td><td>ThermoFisher Scientific</td><td>Cat#D1306</td></tr><tr><td>DNAse I</td><td>Roche</td><td>Cat#10104159001</td></tr><tr><td>HyClone Characterized FBS, Heat-inactivated</td><td>Cytiva Life Science</td><td>Cat#SH30071.03HI</td></tr><tr><td>IFN-&#x003b1; recombinant protein (mouse)</td><td>PBL Assay Science</td><td>Cat#12100-1</td></tr><tr><td>IFN-&#x003b3; recombinant protein (mouse)</td><td>Prepotech</td><td>Cat#315-05-100ug</td></tr><tr><td>MojoSort&#x02122; Buffer</td><td>BioLegend</td><td>Cat#480017</td></tr><tr><td>Penicillin-Streptomycin Solution 100x</td><td>Corning</td><td>Cat#30-002-CI</td></tr><tr><td>Percoll</td><td>Cytiva Life Science</td><td>Cat#17089101</td></tr><tr><td>RPMI-1640 media with L-glutamine</td><td>Cytiva Life Science</td><td>Cat#SH30027.01</td></tr><tr><td>UltraComp eBeads&#x02122; Compensation Beads</td><td>Invitrogen</td><td>Cat#01-2222-41</td></tr><tr><td>UltraPure&#x02122; 0.5M EDTA, pH 8.0</td><td>Invitrogen</td><td>Cat#15575020</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Critical commercial assays</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit</td><td>Invitrogen</td><td>Cat#L-34975 (80 assays)</td></tr><tr><td>MojoSort Mouse CD4&#x000a0;T Cell Isolation Kit</td><td>BioLegend</td><td>Cat#480006 (100 tests)</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Deposited data</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Single-cell RNA-seq data</td><td>Gene Expression Omnibus</td><td><ext-link ext-link-type="uri" xlink:href="ncbi-geo:GSE198466" id="intref0010">GSE198466</ext-link></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Experimental models: Organisms/strains</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>C57BL/6 mice</td><td>Jackson Laboratory</td><td>Strain # 000664</td></tr><tr><td>Ifngr1 knockout mice</td><td>Jackson Laboratory</td><td>Strain # 003288</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Oligonucleotides</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Ifi204 (Mm00492602_m1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Mx1 (Mm00487796_m1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Pml (Mm00476969_m1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Slfn5 (Mm00806095_m1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Ifit1 (Mm00515153_m1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Ifit3 (Mm01704846_s1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Ifitm3 (Mm00847057_s1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>Il17a (Mm00439618_m1)</td><td>Life Technologies</td><td>Cat#4331182</td></tr><tr><td>18S (Hs99999901_s1)</td><td>Life Technologies</td><td>Cat#4319413E</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Software and algorithms</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>Adobe Illustrator 2020</td><td>Adobe</td><td>Version 24.3</td></tr><tr><td>FlowJo X</td><td>BD</td><td>FlowJo 10.8.1</td></tr><tr><td>Prism 9</td><td>GraphPad Software, LLC</td><td>9.0.0 (86)</td></tr><tr><td>bcl2fastq</td><td>Illumina</td><td>2.20.0.422</td></tr><tr><td>Cell Ranger</td><td>10x Genomics</td><td>3.1.0</td></tr><tr><td>Seurat</td><td><xref rid="bib20" ref-type="bibr">Hao et&#x000a0;al. (2021)</xref></td><td>4.0</td></tr><tr><td>ClusterProfiler</td><td><xref rid="bib53" ref-type="bibr">Wu et&#x000a0;al. (2021)</xref></td><td>4.0.5</td></tr><tr><td>TRUST4</td><td><xref rid="bib45" ref-type="bibr">Song et&#x000a0;al. (2021)</xref></td><td>1.0.4</td></tr><tr><td>Velocyto</td><td><xref rid="bib26" ref-type="bibr">La Manno et&#x000a0;al. (2018)</xref></td><td>0.17.17</td></tr><tr><td>ScVelo</td><td><xref rid="bib5" ref-type="bibr">Bergen et&#x000a0;al. (2020)</xref></td><td>0.2.4</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td colspan="3"><bold>Other</bold></td></tr><tr><td colspan="3"><hr/></td></tr><tr><td>EasyEights&#x02122; EasySep&#x02122; Magnet</td><td>STEMCELL Technologies</td><td>Cat#18103</td></tr><tr><td>gentleMACS&#x02122; C Tubes</td><td>Miltenyi Biotec</td><td>Cat#130-093-237</td></tr><tr><td>gentleMACS&#x02122; Octo Dissociator</td><td>Miltenyi Biotec</td><td>Cat#130-095-937</td></tr><tr><td>MojoSort Magnet</td><td>BioLegend</td><td>Cat#480019</td></tr></tbody></table></table-wrap>
</p></sec><sec id="sec4.2"><title>Resource availability</title><sec id="sec4.2.1"><title>Lead contact</title><p id="p0185">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Bruce Klein (<ext-link ext-link-type="uri" xlink:href="mailto:bsklein@wisc.edu" id="intref0015">bsklein@wisc.edu</ext-link>).</p></sec><sec id="sec4.2.2"><title>Materials availability</title><p id="p0190">This study did not generate new materials or reagents.</p></sec></sec><sec id="sec4.3"><title>Experimental model and subject details</title><sec id="sec4.3.1"><title>Mice</title><p id="p0195"><italic>C57BL/6</italic> and <italic>Ifngr1</italic><sup>&#x02212;/&#x02212;</sup> mice from Jackson Laboratory were bred at our facility and cared for per guidelines from the University of Wisconsin Animal Care Committee, who approved all aspects of this work. Male and female mice were 7&#x02013;8&#x000a0;weeks old at the start of experiments. Mice were vaccinated intranasally (IN) or subcutaneously (SC) with 10&#x000a0;&#x003bc;g of Bl-Eng2 in glucan chitin particles (CGP) a total of three times, two weeks apart. Two weeks after the final vaccination, mice were challenged intratracheally with 2x10<sup>4</sup><italic>Blastomycesdermatitidis</italic> (<italic>Bd</italic>, ATCC strain 26199) and analyzed at day 3 post-infection.</p></sec></sec><sec id="sec4.4"><title>Method details</title><sec id="sec4.4.1"><title>Flow cytometry</title><p id="p0200">We harvested cells from a total of 24 mice: 10 vaccinated SC and 14 vaccinated IN. Cells were prepared from harvested lungs as described previously and pooled for each group (<xref rid="bib8" ref-type="bibr">Dobson et&#x000a0;al., 2020</xref>). Briefly, lungs were harvested from challenged animals and dissociated in Miltenyi MACS tubes (Miltenyi Inc., Germany) and digested with collagenase (1&#x000a0;mg/mL) and DNase (1&#x000a0;&#x003bc;g/mL) for 25&#x02009;min at 37&#x000b0;C. Digested lungs were resuspended in 5&#x02009;mL of 40% percoll, and 3&#x02009;mL of 66% percoll was underlaid (GE healthcare 17&#x02013;0891&#x02013;01). Samples were spun for 20&#x02009;min at 2000&#x000a0;rpm at room temperature. Lymphocytes were then harvested from the buffy coat layer and resuspended in complete RPMI (10% FBS, 1% penicillin and streptomycin). The cells were spun down (1500&#x000a0;rpm/5&#x000a0;minutes at room temperature) and stained with LIVE/DEAD&#x02122; Fixable Near-IR Dead Cell Stain Kit (Invitrogen) and Fc Block (BD) for 10&#x02009;min at room temperature. Then the cells were stained with Bl-Eng2 tetramer (MHC class II tetramer-PE, NIH) for 1 hour at room temperature, and 30&#x000a0;minutes at 4&#x000b0;C with the following surface antibodies: CD8 PerCP-Cy5.5 (clone 53&#x02013;6.7, Biolegend, cat#100734), CD44 BV650 (clone IM7, Biolegend, cat#103049), CD11b APC (clone M1/70, Biolegend, cat#101212), CD11c APC (clone N418, Biolegend, cat#117310), NK1.1 APC (clone PK136, Biolegend, cat#108710), B220 APC (clone RA3&#x02013;62B, Biolegend, cat#103212), CD4 BUV737 (clone RM4&#x02013;5, BD, cat#565246), and CD90.2 BV421 (clone 30-H12, Biolegend, cat105341). All panels included a dump channel to decrease background in CD4<sup>+</sup>T cells (Dump: CD11b, CD11c, NK1.1, and B220). The cells were sorted using the cell sorting flow cytometer FACSAria (BD). Following fluorescent labeling, cells from 10-15 animals from each vaccine (SC or IN) group were combined into one tube each for cell sorting. Tetramer<sup>+</sup> cells were sorted into microcentrifuge tubes containing RPMI media on a FACs Aria using a 130 micron nozzle. The sorted cells (Live, Dump<sup>&#x02212;</sup>CD90.2<sup>+</sup>CD4<sup>+</sup>CD44<sup>+</sup>Tetramer<sup>+</sup>) were collected directly into 1.5&#x000a0;ml microtubes and provided to the UW-Madison Biotechnology Center for 10x Genomics Single Cell RNA sequencing.</p></sec><sec id="sec4.4.2"><title>Single-cell RNA-seq libraries</title><p id="p0205">Sorted tetramer<sup>+</sup> cells were counted on a Countless II cell counter with 0.4% trypan blue and concentrated to 300&#x02013;400 cells/ml (total volume of 43.3&#x000a0;ml) and reverse transcribed. The libraries were generated with the 3&#x02032; kit version 3.1 chemistry (10x Genomics) and sequenced on the MiSeq system and the NovaSeq 6000.</p></sec><sec id="sec4.4.3"><title>Single-cell RNA-seq data analysis</title><p id="p0210">Single cell RNAseq data was initially processed by the UW Bioinformatics Resource Center. Experiment data was demultiplexed using the Cell Ranger Single Cell Software Suite, mkfastq command wrapped around Illumina&#x02019;s bcl2fastq (v2.20.0.422). The MiSeq balancing run was quality controlled using calculations based on UMI-tools (<xref rid="bib44" ref-type="bibr">Smith et&#x000a0;al., 2017</xref>). Samples libraries were balanced for the number of estimated reads per cell and run on an Illumina NovaSeq system. Cell Ranger software version 3.1.0 was then used to perform demultiplexing, alignment, filtering, barcode counting, UMI counting, and gene expression estimation for each sample according to the 10x Genomics documentation (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-iscell-ranger" id="intref0020">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-iscell-ranger</ext-link>). The reference for alignment was the curated 10x genomics reference for mouse (mm10&#x02013;3.0.0). The gene expression estimates from each sample were then aggregated using Cellranger (cellranger aggr) to compare experimental groups with normalized sequencing-depth and expression data.</p><p id="p0215">Single-cell expression data was then analyzed using Seurat 4.0 (<xref rid="bib20" ref-type="bibr">Hao et&#x000a0;al., 2021</xref>). Genes detected in fewer than 5 cells were filtered out of analysis. Doublets were removed from analysis, and cells with &#x0003c;2000 or &#x0003e;20,000 unique molecular identifiers (UMI) or &#x0003c;1000 or &#x0003e;3000 genes were excluded from analysis. Cells with elevated percentage of mitochondrial reads (&#x0003e;5%) were also excluded as a means to filter out dying cells. Ultimately 70.0% of cells IN and 80.1% of cells SC passed quality control filters. Data were normalized using the NormalizeData function, and IN and SC samples were integrated for downstream analysis using FindIntegrationAnchors and IntegrateData functions (<xref rid="bib47" ref-type="bibr">Stuart et&#x000a0;al., 2019</xref>). Clustering and visualization for the integrated dataset proceeded with a standard scRNAseq workflow including ScaleData, RunPCA, RunUMAP, FindNeighbors and FindClusters functions. FindClusters was run with resolution parameter 0.83 to achieve clusters that separated cell populations with previously established markers. Cluster markers were obtained with FindMarkers function (min.pct&#x000a0;= 0.25). Dimension-reduced plots were generated with FeaturePlot function, splitting by original sample identity as needed for specific analyses. Heatmaps were produced with DoHeatmap function using cluster averages across both experiments calculated with AverageExpression function. Bar plots and scatterplots were generated using R package ggplot2. Gene set enrichment analysis was performed using the clusterProfiler R package using the CellMarker set of mouse cell type markers (<xref rid="bib53" ref-type="bibr">Wu et&#x000a0;al., 2021</xref>; <xref rid="bib57" ref-type="bibr">Zhang et&#x000a0;al., 2019</xref>). Specifically, the clusterProfiler function &#x0201c;GSEA&#x0201d; was run using a list of genes sorted by descending log2 fold change from the comparison of cells in one cluster vs. all others, as calculated by the Seurat FindMarkers function (logfc.threshold&#x000a0;= 0). Scoring and prediction of cell cycle stage was performed using the Seurat CellCycleScoring function, with the lists of S and G2M genes provided by Seurat.</p></sec><sec id="sec4.4.4"><title>TCR usage analysis</title><p id="p0220">TCR sequence data was analyzed using TRUST4 v1.0.4.(<xref rid="bib45" ref-type="bibr">Song et&#x000a0;al., 2021</xref>) TRUST4 was run on the position sorted BAM file for each sample generated by CellRanger, along with the V/D/J/C gene reference files provided by TRUST4 (&#x0201c;GRCm38_bcrtcr.fa&#x0201d; and &#x0201c;mouse_IMGT+C.fa&#x0201d;), and the &#x0201c;--barcode CB&#x0201d; option to make clonotype calls for individual cells. The resulting &#x0201c;barcode_report.tsv&#x0201d; output files, which report the most abundant pair of alpha and beta chains for each cell, were summarized within R. The TRUST4 output was filtered for those cells that were retained in the Seurat analysis and for which the predicted cell type was &#x0201c;abT&#x0201d;. For both the alpha and beta chains, the clonotype was defined as the concatenation of the V and J segments, due to limited calls for the D segment of beta chains. Relative frequencies of clonotypes were computed at both the sample and individual cluster level.</p></sec><sec id="sec4.4.5"><title>RNA velocity analysis</title><p id="p0225">Unspliced and splice read counts were computed using velocyto v0.17.17 (<xref rid="bib26" ref-type="bibr">La Manno et&#x000a0;al., 2018</xref>). As input for each sample, velocyto (with the &#x0201c;run10x&#x0201d; command) was given the output directory of CellRanger, the CellRanger mouse reference gene annotation (mm10, v3.0.0), and an annotation of repetitive elements for the mouse genome (mm10 RepeatMasker track downloaded from the UCSC Genome Browser in GTF format) (<xref rid="bib33" ref-type="bibr">Navarro Gonzalez et&#x000a0;al., 2021</xref>). The resulting read counts were analyzed with the scVelo v0.2.4 Python package (<xref rid="bib5" ref-type="bibr">Bergen et&#x000a0;al., 2020</xref>). Cells were filtered to those that were analyzed with Seurat and annotated with the Seurat-computed clusters. After standard preprocessing documented by scVelo, velocities were computed using its &#x0201c;stochastic&#x0201d; model. Genes with velocities that were significantly higher in one cluster compared to cells from all other clusters were identified using the &#x0201c;rank_velocity_genes&#x0201d; method (with min_corr&#x000a0;=0.3).</p></sec><sec id="sec4.4.6"><title>RT-qPCR experiments</title><p id="p0230">CD44<sup>+</sup>Tetramer<sup>+</sup> cells were harvested from lung and spleen following vaccination and pathogen challenge described above. The lungs were processed, stained, and sorted in the same manner as explained before for scRNAseq. Spleens were mashed through 40&#x02009;&#x003bc;m filters, and then subjected to red blood cell lysis (ACK buffer, Gibco&#x02122;, Cat#A1049201) for 3&#x000a0;minutes at room temperature. Samples were washed with 15&#x02009;mL of wash buffer (RPMI with 1% FBS) and the CD4<sup>+</sup>T cells were enriched using MojoSort&#x02122; Mouse CD4 cell isolation (Biolegend, Cat#480006). The cells were stained and sorted as explained before in scRNAseq section as well. Both lungs and spleen were sorted in 1.5&#x000a0;ml microtubes with 0.5% BSA in PBS 30&#x000a0;minutes after surface staining and kept at 4&#x000b0;C. Lung and spleen cells were not fixed after surface staining and sorted in sterile condition in order to perform <italic>in&#x000a0;vitro</italic> stimulation experiments. The samples were pooled after surface staining step (3&#x02013;4 mice/sample, total of 3 samples).</p><p id="p0235">For stimulation studies, cells from lung or spleen (50,000&#x02013;200,000 cells/well) were left unstimulated (RPMI with 0.5% BSA) or stimulated with IFN&#x003b1; (10,000 units/mL) or IFN&#x003b3; (10&#x000a0;ng/ml) and analyzed by RT-qPCR at 12 hours. To measure mRNA expression levels of genes, cDNA was generated directly from cell lysate using the Invitrogen SuperScript IV CellsDirect cDNA Synthesis Kit (ThermoFisher Scientific, 11750150). qPCR was performed on a Rotor-Gene Q system (Qiagen) using TaqMan Gene Expression Assays (ThermoFisher Scientific, Ifi204 Mm00492602_m1; Mx1 Mm00487796_m1; Pml Mm00476969_m1; Slfn5 Mm00806095_m1; Ifit1 Mm00515153_m1; Ifitm3 Mm00847057_s1; Il17a Mm00439618_m1; 18S 4319413E) and TaqMan Fast Advanced Master Mix (ThermoFisher Scientific, 4444556). Relative quantification was performed by the &#x00394;&#x00394;CT method with 18S as a reference gene.</p></sec></sec><sec id="sec4.5"><title>Quantification and statistical analysis</title><p id="p0240">Number of biological replicates is stated in each legend. Data are expressed as mean&#x000a0;&#x000b1; SD or SEM as indicated. Pairwise comparisons between two groups were analyzed by unpaired Student&#x02019;s t test. p values are indicated on graphs as appropriate. Mann Whitney U test was used to compare differences between two groups when data were not normally distributed. &#x02217;p&#x000a0;&#x0003c;&#x000a0;0.05, &#x02217;&#x02217;p&#x000a0;&#x0003c;&#x000a0;0.01 and &#x02217;&#x02217;&#x02217;p&#x000a0;&#x0003c;&#x000a0;0.001. Detailed information can be found in the respective figure legends.</p></sec><sec id="sec4.6"><title>Additional resources</title><p id="p0245">None.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Andreatta</surname><given-names>M.</given-names></name><name><surname>Corria-Osorio</surname><given-names>J.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>S.</given-names></name><name><surname>Cubas</surname><given-names>R.</given-names></name><name><surname>Coukos</surname><given-names>G.</given-names></name><name><surname>Carmona</surname><given-names>S.J.</given-names></name></person-group><article-title>Interpretation of T&#x000a0;cell states from single-cell transcriptomics data using reference atlases</article-title><source>Nat. Commun.</source><volume>12</volume><year>2021</year><fpage>2965</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-23324-4</pub-id><pub-id pub-id-type="pmid">34017005</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Arazi</surname><given-names>A.</given-names></name><name><surname>Rao</surname><given-names>D.A.</given-names></name><name><surname>Berthier</surname><given-names>C.C.</given-names></name><name><surname>Davidson</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Hoover</surname><given-names>P.J.</given-names></name><name><surname>Chicoine</surname><given-names>A.</given-names></name><name><surname>Eisenhaure</surname><given-names>T.M.</given-names></name><name><surname>Jonsson</surname><given-names>A.H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group><article-title>The immune cell landscape in kidneys of patients with lupus nephritis</article-title><source>Nat. Immunol.</source><volume>20</volume><year>2019</year><fpage>902</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0398-x</pub-id><pub-id pub-id-type="pmid">31209404</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>E.A.</given-names></name><name><surname>Aguet</surname><given-names>M.</given-names></name><name><surname>Schreiber</surname><given-names>R.D.</given-names></name></person-group><article-title>The IFN gamma receptor: a paradigm for cytokine receptor signaling</article-title><source>Annu. Rev. Immunol.</source><volume>15</volume><year>1997</year><fpage>563</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.15.1.563</pub-id><pub-id pub-id-type="pmid">9143700</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>E.A.</given-names></name><name><surname>Szabo</surname><given-names>S.J.</given-names></name><name><surname>Dighe</surname><given-names>A.S.</given-names></name><name><surname>Ashkenazi</surname><given-names>A.</given-names></name><name><surname>Aguet</surname><given-names>M.</given-names></name><name><surname>Murphy</surname><given-names>K.M.</given-names></name><name><surname>Schreiber</surname><given-names>R.D.</given-names></name></person-group><article-title>Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper cell subsets</article-title><source>Science</source><volume>270</volume><year>1995</year><fpage>1215</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1126/science.270.5239.1215</pub-id><pub-id pub-id-type="pmid">7502050</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Bergen</surname><given-names>V.</given-names></name><name><surname>Lange</surname><given-names>M.</given-names></name><name><surname>Peidli</surname><given-names>S.</given-names></name><name><surname>Wolf</surname><given-names>F.A.</given-names></name><name><surname>Theis</surname><given-names>F.J.</given-names></name></person-group><article-title>Generalizing RNA velocity to transient cell states through dynamical modeling</article-title><source>Nat. Biotechnol.</source><volume>38</volume><year>2020</year><fpage>1408</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0591-3</pub-id><pub-id pub-id-type="pmid">32747759</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>N.</given-names></name><name><surname>Janumyan</surname><given-names>Y.M.</given-names></name><name><surname>Didion</surname><given-names>L.</given-names></name><name><surname>Van Hofwegen</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>E.</given-names></name><name><surname>Knudson</surname><given-names>C.M.</given-names></name></person-group><article-title>Bcl-2 inhibition of T-cell proliferation is related to prolonged T-cell survival</article-title><source>Oncogene</source><volume>23</volume><year>2004</year><fpage>3770</fpage><lpage>3780</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1207478</pub-id><pub-id pub-id-type="pmid">15034548</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Debes</surname><given-names>G.F.</given-names></name><name><surname>Arnold</surname><given-names>C.N.</given-names></name><name><surname>Young</surname><given-names>A.J.</given-names></name><name><surname>Krautwald</surname><given-names>S.</given-names></name><name><surname>Lipp</surname><given-names>M.</given-names></name><name><surname>Hay</surname><given-names>J.B.</given-names></name><name><surname>Butcher</surname><given-names>E.C.</given-names></name></person-group><article-title>Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues</article-title><source>Nat. Immunol.</source><volume>6</volume><year>2005</year><fpage>889</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1038/ni1238</pub-id><pub-id pub-id-type="pmid">16116468</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>H.E.</given-names></name><name><surname>Dias</surname><given-names>L.D.S.</given-names></name><name><surname>Kohn</surname><given-names>E.M.</given-names></name><name><surname>Fites</surname><given-names>S.</given-names></name><name><surname>Wiesner</surname><given-names>D.L.</given-names></name><name><surname>Dileepan</surname><given-names>T.</given-names></name><name><surname>Kujoth</surname><given-names>G.C.</given-names></name><name><surname>Abraham</surname><given-names>A.</given-names></name><name><surname>Ostroff</surname><given-names>G.R.</given-names></name><name><surname>Klein</surname><given-names>B.S.</given-names></name><name><surname>W&#x000fc;thrich</surname><given-names>M.</given-names></name></person-group><article-title>Antigen discovery unveils resident memory and migratory cell roles in antifungal resistance</article-title><source>Mucosal Immunol.</source><volume>13</volume><year>2020</year><fpage>518</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/s41385-019-0244-3</pub-id><pub-id pub-id-type="pmid">31900406</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Duclos</surname><given-names>P.</given-names></name><name><surname>Okwo-Bele</surname><given-names>J.M.</given-names></name><name><surname>Gacic-Dobo</surname><given-names>M.</given-names></name><name><surname>Cherian</surname><given-names>T.</given-names></name></person-group><article-title>Global immunization: status, progress, challenges and future</article-title><source>BMC Int. Health Hum. Rights</source><volume>9</volume><year>2009</year><fpage>S2</fpage><pub-id pub-id-type="doi">10.1186/1472-698X-9-S1-S2</pub-id><pub-id pub-id-type="pmid">19828060</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G.</given-names></name><name><surname>Lees</surname><given-names>R.</given-names></name><name><surname>Smiley</surname><given-names>S.T.</given-names></name><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Grusby</surname><given-names>M.J.</given-names></name><name><surname>MacDonald</surname><given-names>H.R.</given-names></name></person-group><article-title>Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T&#x000a0;cells</article-title><source>J.&#x000a0;Immunol.</source><volume>162</volume><year>1999</year><fpage>6410</fpage><lpage>6419</lpage><pub-id pub-id-type="pmid">10352254</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Emming</surname><given-names>S.</given-names></name><name><surname>Bianchi</surname><given-names>N.</given-names></name><name><surname>Polletti</surname><given-names>S.</given-names></name><name><surname>Balestrieri</surname><given-names>C.</given-names></name><name><surname>Leoni</surname><given-names>C.</given-names></name><name><surname>Montagner</surname><given-names>S.</given-names></name><name><surname>Chirichella</surname><given-names>M.</given-names></name><name><surname>Delaleu</surname><given-names>N.</given-names></name><name><surname>Natoli</surname><given-names>G.</given-names></name><name><surname>Monticelli</surname><given-names>S.</given-names></name></person-group><article-title>A molecular network regulating the proinflammatory phenotype of human memory T lymphocytes</article-title><source>Nat. Immunol.</source><volume>21</volume><year>2020</year><fpage>388</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0622-8</pub-id><pub-id pub-id-type="pmid">32205878</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Engel</surname><given-names>I.</given-names></name><name><surname>Seumois</surname><given-names>G.</given-names></name><name><surname>Chavez</surname><given-names>L.</given-names></name><name><surname>Samaniego-Castruita</surname><given-names>D.</given-names></name><name><surname>White</surname><given-names>B.</given-names></name><name><surname>Chawla</surname><given-names>A.</given-names></name><name><surname>Mock</surname><given-names>D.</given-names></name><name><surname>Vijayanand</surname><given-names>P.</given-names></name><name><surname>Kronenberg</surname><given-names>M.</given-names></name></person-group><article-title>Innate-like functions of natural killer T&#x000a0;cell subsets result from highly divergent gene programs</article-title><source>Nat. Immunol.</source><volume>17</volume><year>2016</year><fpage>728</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1038/ni.3437</pub-id><pub-id pub-id-type="pmid">27089380</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Everitt</surname><given-names>A.R.</given-names></name><name><surname>Clare</surname><given-names>S.</given-names></name><name><surname>Pertel</surname><given-names>T.</given-names></name><name><surname>John</surname><given-names>S.P.</given-names></name><name><surname>Wash</surname><given-names>R.S.</given-names></name><name><surname>Smith</surname><given-names>S.E.</given-names></name><name><surname>Chin</surname><given-names>C.R.</given-names></name><name><surname>Feeley</surname><given-names>E.M.</given-names></name><name><surname>Sims</surname><given-names>J.S.</given-names></name><name><surname>Adams</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>IFITM3 restricts the morbidity and mortality associated with influenza</article-title><source>Nature</source><volume>484</volume><year>2012</year><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/nature10921</pub-id><pub-id pub-id-type="pmid">22446628</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Farr</surname><given-names>A.R.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Choi</surname><given-names>B.</given-names></name><name><surname>Cavalcoli</surname><given-names>J.D.</given-names></name><name><surname>Laouar</surname><given-names>Y.</given-names></name></person-group><article-title>CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>111</volume><year>2014</year><fpage>12841</fpage><lpage>12846</lpage><pub-id pub-id-type="doi">10.1073/pnas.1323405111</pub-id><pub-id pub-id-type="pmid">25143585</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="other" id="sref15"><person-group person-group-type="author"><name><surname>Galvani</surname><given-names>A.</given-names></name><name><surname>Modhadas</surname><given-names>S.</given-names></name><name><surname>Schneider</surname><given-names>E.</given-names></name></person-group><article-title>Deaths and Hospitalizations Averted by Rapid US Vaccine Rollout</article-title><ext-link ext-link-type="uri" xlink:href="https://www.commonwealthfund.org/publications/issue-briefs/2021/jul/deaths-and-hospitalizations-averted-rapid-us-vaccination-rollout" id="intref0030">https://www.commonwealthfund.org/publications/issue-briefs/2021/jul/deaths-and-hospitalizations-averted-rapid-us-vaccination-rollout</ext-link><year>2021</year></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>A.V.</given-names></name><name><surname>Amatya</surname><given-names>N.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Cruz</surname><given-names>J.A.</given-names></name><name><surname>Grover</surname><given-names>P.</given-names></name><name><surname>Whibley</surname><given-names>N.</given-names></name><name><surname>Conti</surname><given-names>H.R.</given-names></name><name><surname>Hernandez Mir</surname><given-names>G.</given-names></name><name><surname>Sirakova</surname><given-names>T.</given-names></name><name><surname>Childs</surname><given-names>E.C.</given-names></name><etal/></person-group><article-title>MCPIP1 endoribonuclease activity negatively regulates interleukin-17-mediated signaling and inflammation</article-title><source>Immunity</source><volume>43</volume><year>2015</year><fpage>475</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2015.07.021</pub-id><pub-id pub-id-type="pmid">26320658</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Giroux</surname><given-names>M.</given-names></name><name><surname>Denis</surname><given-names>F.</given-names></name></person-group><article-title>CD1d-unrestricted human NKT cells release chemokines upon Fas engagement</article-title><source>Blood</source><volume>105</volume><year>2005</year><fpage>703</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1182/blood-2004-04-1537</pub-id><pub-id pub-id-type="pmid">15345586</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Godfrey</surname><given-names>D.I.</given-names></name><name><surname>MacDonald</surname><given-names>H.R.</given-names></name><name><surname>Kronenberg</surname><given-names>M.</given-names></name><name><surname>Smyth</surname><given-names>M.J.</given-names></name><name><surname>Van Kaer</surname><given-names>L.</given-names></name></person-group><article-title>NKT cells: what's in a name?</article-title><source>Nat. Rev. Immunol.</source><volume>4</volume><year>2004</year><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1038/nri1309</pub-id><pub-id pub-id-type="pmid">15039760</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Gowthaman</surname><given-names>U.</given-names></name><name><surname>Chen</surname><given-names>J.S.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Flynn</surname><given-names>W.F.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>W.</given-names></name><name><surname>Joseph</surname><given-names>J.</given-names></name><name><surname>Gertie</surname><given-names>J.A.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Collet</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Identification of a T follicular helper cell subset that drives anaphylactic IgE</article-title><source>Science</source><volume>365</volume><year>2019</year><fpage>eaaw6433</fpage><pub-id pub-id-type="doi">10.1126/science.aaw6433</pub-id><pub-id pub-id-type="pmid">31371561</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Hao</surname><given-names>S.</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E.</given-names></name><name><surname>Mauck</surname><given-names>W.M.</given-names></name><name><surname>Zheng</surname><given-names>S.</given-names></name><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>M.J.</given-names></name><name><surname>Wilk</surname><given-names>A.J.</given-names></name><name><surname>Darby</surname><given-names>C.</given-names></name><name><surname>Zager</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><year>2021</year><fpage>3573</fpage><lpage>3587.e29</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Harsha Krovi</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Michaels-Foster</surname><given-names>M.J.</given-names></name><name><surname>Brunetti</surname><given-names>T.</given-names></name><name><surname>Loh</surname><given-names>L.</given-names></name><name><surname>Scott-Browne</surname><given-names>J.</given-names></name><name><surname>Gapin</surname><given-names>L.</given-names></name></person-group><article-title>Thymic iNKT single cell analyses unmask the common developmental program of mouse innate T&#x000a0;cells</article-title><source>Nat. Commun.</source><volume>11</volume><year>2020</year><fpage>6238</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-20073-8</pub-id><pub-id pub-id-type="pmid">33288744</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Heaton</surname><given-names>P.M.</given-names></name></person-group><article-title>Challenges of developing novel vaccines with particular global health importance</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>517290</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2020.517290</pub-id><pub-id pub-id-type="pmid">33162972</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Huppler</surname><given-names>A.R.</given-names></name><name><surname>Bishu</surname><given-names>S.</given-names></name><name><surname>Gaffen</surname><given-names>S.L.</given-names></name></person-group><article-title>Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy</article-title><source>Arthritis Res. Ther.</source><volume>14</volume><year>2012</year><fpage>217</fpage><pub-id pub-id-type="doi">10.1186/ar3893</pub-id><pub-id pub-id-type="pmid">22838497</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="book" id="sref24"><person-group person-group-type="author"><name><surname>Kiner</surname><given-names>E.</given-names></name></person-group><part-title>Heterogeneity of CD4+ T Cells</part-title><year>2019</year><publisher-name>HUL.InstRepos</publisher-name><ext-link ext-link-type="uri" xlink:href="http://nrs.harvard.edu/urn-3" id="intref0035">http://nrs.harvard.edu/urn-3</ext-link></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Kiner</surname><given-names>E.</given-names></name><name><surname>Willie</surname><given-names>E.</given-names></name><name><surname>Vijaykumar</surname><given-names>B.</given-names></name><name><surname>Chowdhary</surname><given-names>K.</given-names></name><name><surname>Schmutz</surname><given-names>H.</given-names></name><name><surname>Chandler</surname><given-names>J.</given-names></name><name><surname>Schnell</surname><given-names>A.</given-names></name><name><surname>Thakore</surname><given-names>P.I.</given-names></name><name><surname>LeGros</surname><given-names>G.</given-names></name><name><surname>Mostafavi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Gut CD4<sup>+</sup> T&#x000a0;cell phenotypes are a continuum molded by microbes, not by T<sub>H</sub> archetypes</article-title><source>Nat. Immunol.</source><volume>22</volume><year>2021</year><fpage>216</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-00836-7</pub-id><pub-id pub-id-type="pmid">33462454</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>La Manno</surname><given-names>G.</given-names></name><name><surname>Soldatov</surname><given-names>R.</given-names></name><name><surname>Zeisel</surname><given-names>A.</given-names></name><name><surname>Braun</surname><given-names>E.</given-names></name><name><surname>Hochgerner</surname><given-names>H.</given-names></name><name><surname>Petukhov</surname><given-names>V.</given-names></name><name><surname>Lidschreiber</surname><given-names>K.</given-names></name><name><surname>Kastriti</surname><given-names>M.E.</given-names></name><name><surname>L&#x000f6;nnerberg</surname><given-names>P.</given-names></name><name><surname>Furlan</surname><given-names>A.</given-names></name><etal/></person-group><article-title>RNA velocity of single cells</article-title><source>Nature</source><volume>560</volume><year>2018</year><fpage>494</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0414-6</pub-id><pub-id pub-id-type="pmid">30089906</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>A.P.</given-names></name><name><surname>Ishizuka</surname><given-names>I.E.</given-names></name><name><surname>Kasal</surname><given-names>D.N.</given-names></name><name><surname>Mandal</surname><given-names>M.</given-names></name><name><surname>Bendelac</surname><given-names>A.</given-names></name></person-group><article-title>A shared Runx1-bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development</article-title><source>Nat. Commun.</source><volume>8</volume><year>2017</year><fpage>863</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00882-0</pub-id><pub-id pub-id-type="pmid">29038474</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>K.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Standley</surname><given-names>D.M.</given-names></name><name><surname>Kumagai</surname><given-names>Y.</given-names></name><name><surname>Kawagoe</surname><given-names>T.</given-names></name><name><surname>Miyake</surname><given-names>T.</given-names></name><name><surname>Satoh</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>H.</given-names></name><name><surname>Tsujimura</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>H.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group><article-title>Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay</article-title><source>Nature</source><volume>458</volume><year>2009</year><fpage>1185</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1038/nature07924</pub-id><pub-id pub-id-type="pmid">19322177</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Merkhofer</surname><given-names>R.M.</given-names></name><name><surname>O'Neill</surname><given-names>M.B.</given-names></name><name><surname>Xiong</surname><given-names>D.</given-names></name><name><surname>Hernandez-Santos</surname><given-names>N.</given-names></name><name><surname>Dobson</surname><given-names>H.</given-names></name><name><surname>Fites</surname><given-names>J.S.</given-names></name><name><surname>Shockey</surname><given-names>A.C.</given-names></name><name><surname>Wuethrich</surname><given-names>M.</given-names></name><name><surname>Pepperell</surname><given-names>C.S.</given-names></name><name><surname>Klein</surname><given-names>B.S.</given-names></name></person-group><article-title>Investigation of genetic susceptibility to blastomycosis reveals interleukin-6 as a potential susceptibility locus</article-title><source>mBio</source><volume>10</volume><year>2019</year><fpage>e01224-19</fpage><pub-id pub-id-type="doi">10.1128/mBio.01224-19</pub-id><pub-id pub-id-type="pmid">31213563</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Miragaia</surname><given-names>R.J.</given-names></name><name><surname>Gomes</surname><given-names>T.</given-names></name><name><surname>Chomka</surname><given-names>A.</given-names></name><name><surname>Jardine</surname><given-names>L.</given-names></name><name><surname>Riedel</surname><given-names>A.</given-names></name><name><surname>Hegazy</surname><given-names>A.N.</given-names></name><name><surname>Whibley</surname><given-names>N.</given-names></name><name><surname>Tucci</surname><given-names>A.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Lindeman</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Single-cell transcriptomics of regulatory T&#x000a0;cells reveals trajectories of tissue adaptation</article-title><source>Immunity</source><volume>50</volume><year>2019</year><fpage>493</fpage><lpage>504.e7</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.01.001</pub-id><pub-id pub-id-type="pmid">30737144</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Monaco</surname><given-names>G.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Mustafah</surname><given-names>S.</given-names></name><name><surname>Hwang</surname><given-names>Y.Y.</given-names></name><name><surname>Carr&#x000e9;</surname><given-names>C.</given-names></name><name><surname>Burdin</surname><given-names>N.</given-names></name><name><surname>Visan</surname><given-names>L.</given-names></name><name><surname>Ceccarelli</surname><given-names>M.</given-names></name><name><surname>Poidinger</surname><given-names>M.</given-names></name><etal/></person-group><article-title>RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types</article-title><source>Cell Rep.</source><volume>26</volume><year>2019</year><fpage>1627</fpage><lpage>1640.e7</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.041</pub-id><pub-id pub-id-type="pmid">30726743</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>R.</given-names></name><name><surname>Kershaw</surname><given-names>N.J.</given-names></name><name><surname>Babon</surname><given-names>J.J.</given-names></name></person-group><article-title>The molecular details of cytokine signaling via the JAK/STAT pathway</article-title><source>Protein Sci.</source><volume>27</volume><year>2018</year><fpage>1984</fpage><lpage>2009</lpage><pub-id pub-id-type="doi">10.1002/pro.3519</pub-id><pub-id pub-id-type="pmid">30267440</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Navarro Gonzalez</surname><given-names>J.</given-names></name><name><surname>Zweig</surname><given-names>A.S.</given-names></name><name><surname>Speir</surname><given-names>M.L.</given-names></name><name><surname>Schmelter</surname><given-names>D.</given-names></name><name><surname>Rosenbloom</surname><given-names>K.R.</given-names></name><name><surname>Raney</surname><given-names>B.J.</given-names></name><name><surname>Powell</surname><given-names>C.C.</given-names></name><name><surname>Nassar</surname><given-names>L.R.</given-names></name><name><surname>Maulding</surname><given-names>N.D.</given-names></name><name><surname>Lee</surname><given-names>C.M.</given-names></name><etal/></person-group><article-title>The UCSC Genome Browser database: 2021 update</article-title><source>Nucleic Acids Res.</source><volume>49</volume><year>2021</year><fpage>D1046</fpage><lpage>D1057</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1070</pub-id><pub-id pub-id-type="pmid">33221922</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>S.S.</given-names></name><name><surname>De Labastida Rivera</surname><given-names>F.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Corvino</surname><given-names>D.</given-names></name><name><surname>Das</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Kuns</surname><given-names>R.</given-names></name><name><surname>Chauhan</surname><given-names>S.B.</given-names></name><name><surname>Hou</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.Y.</given-names></name><etal/></person-group><article-title>The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation</article-title><source>Nat. Immunol.</source><volume>21</volume><year>2020</year><fpage>1205</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1038/s41590-020-0758-6</pub-id><pub-id pub-id-type="pmid">32839608</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Ortiz</surname><given-names>B.D.</given-names></name><name><surname>Krensky</surname><given-names>A.M.</given-names></name><name><surname>Nelson</surname><given-names>P.J.</given-names></name></person-group><article-title>Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation</article-title><source>Mol. Cell Biol.</source><volume>16</volume><year>1996</year><fpage>202</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1128/MCB.16.1.202</pub-id><pub-id pub-id-type="pmid">8524297</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Panagioti</surname><given-names>E.</given-names></name><name><surname>Klenerman</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>L.N.</given-names></name><name><surname>van der Burg</surname><given-names>S.H.</given-names></name><name><surname>Arens</surname><given-names>R.</given-names></name></person-group><article-title>Features of effective T&#x000a0;cell-inducing vaccines against chronic viral infections</article-title><source>Front. Immunol.</source><volume>9</volume><year>2018</year><fpage>276</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00276</pub-id><pub-id pub-id-type="pmid">29503649</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>A.J.</given-names></name><name><surname>Bijker</surname><given-names>E.M.</given-names></name></person-group><article-title>A guide to vaccinology: from basic principles to new developments</article-title><source>Nat. Rev. Immunol.</source><volume>21</volume><year>2021</year><fpage>83</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1038/s41577-020-00479-7</pub-id><pub-id pub-id-type="pmid">33353987</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Prelli Bozzo</surname><given-names>C.</given-names></name><name><surname>Nchioua</surname><given-names>R.</given-names></name><name><surname>Volcic</surname><given-names>M.</given-names></name><name><surname>Koepke</surname><given-names>L.</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>J.</given-names></name><name><surname>Sch&#x000fc;tz</surname><given-names>D.</given-names></name><name><surname>Heller</surname><given-names>S.</given-names></name><name><surname>St&#x000fc;rzel</surname><given-names>C.M.</given-names></name><name><surname>Kmiec</surname><given-names>D.</given-names></name><name><surname>Conzelmann</surname><given-names>C.</given-names></name><etal/></person-group><article-title>IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in&#x000a0;vitro</article-title><source>Nat. Commun.</source><volume>12</volume><year>2021</year><fpage>4584</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-24817-y</pub-id><pub-id pub-id-type="pmid">34321474</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Rezende</surname><given-names>R.M.</given-names></name><name><surname>Weiner</surname><given-names>H.L.</given-names></name></person-group><article-title>History and mechanisms of oral tolerance</article-title><source>Semin.Immunol.</source><volume>30</volume><year>2017</year><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.smim.2017.07.004</pub-id><pub-id pub-id-type="pmid">28774470</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Schenkel</surname><given-names>J.M.</given-names></name><name><surname>Masopust</surname><given-names>D.</given-names></name></person-group><article-title>Tissue-resident memory T&#x000a0;cells</article-title><source>Immunity</source><volume>41</volume><year>2014</year><fpage>886</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.12.007</pub-id><pub-id pub-id-type="pmid">25526304</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>W.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>Kojo</surname><given-names>S.</given-names></name><name><surname>Okeke</surname><given-names>A.</given-names></name><name><surname>Kohwi-Shigematsu</surname><given-names>T.</given-names></name><name><surname>Fujii</surname><given-names>S.I.</given-names></name><name><surname>Taniuchi</surname><given-names>I.</given-names></name></person-group><article-title>Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity</article-title><source>Nat. Commun.</source><volume>11</volume><year>2020</year><fpage>1562</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-15375-w</pub-id><pub-id pub-id-type="pmid">32218434</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Seumois</surname><given-names>G.</given-names></name><name><surname>Ram&#x000ed;rez-Su&#x000e1;stegui</surname><given-names>C.</given-names></name><name><surname>Schmiedel</surname><given-names>B.J.</given-names></name><name><surname>Liang</surname><given-names>S.</given-names></name><name><surname>Peters</surname><given-names>B.</given-names></name><name><surname>Sette</surname><given-names>A.</given-names></name><name><surname>Vijayanand</surname><given-names>P.</given-names></name></person-group><article-title>Single-cell transcriptomic analysis of allergen-specific T&#x000a0;cells in allergy and asthma</article-title><source>Sci. Immunol.</source><volume>5</volume><year>2020</year><fpage>eaba6087</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aba6087</pub-id><pub-id pub-id-type="pmid">32532832</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Singhania</surname><given-names>A.</given-names></name><name><surname>Graham</surname><given-names>C.M.</given-names></name><name><surname>Gabry&#x00161;ov&#x000e1;</surname><given-names>L.</given-names></name><name><surname>Moreira-Teixeira</surname><given-names>L.</given-names></name><name><surname>Stavropoulos</surname><given-names>E.</given-names></name><name><surname>Pitt</surname><given-names>J.M.</given-names></name><name><surname>Chakravarty</surname><given-names>P.</given-names></name><name><surname>Warnatsch</surname><given-names>A.</given-names></name><name><surname>Branchett</surname><given-names>W.J.</given-names></name><name><surname>Conejero</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases</article-title><source>Nat. Commun.</source><volume>10</volume><year>2019</year><fpage>2887</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-10601-6</pub-id><pub-id pub-id-type="pmid">31253760</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>T.</given-names></name><name><surname>Heger</surname><given-names>A.</given-names></name><name><surname>Sudbery</surname><given-names>I.</given-names></name></person-group><article-title>UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy</article-title><source>Genome Res.</source><volume>27</volume><year>2017</year><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1101/gr.209601.116</pub-id><pub-id pub-id-type="pmid">28100584</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Cohen</surname><given-names>D.</given-names></name><name><surname>Ouyang</surname><given-names>Z.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.S.</given-names></name></person-group><article-title>TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data</article-title><source>Nat. Methods</source><volume>18</volume><year>2021</year><fpage>627</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1038/s41592-021-01142-2</pub-id><pub-id pub-id-type="pmid">33986545</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Speakman</surname><given-names>E.A.</given-names></name><name><surname>Dambuza</surname><given-names>I.M.</given-names></name><name><surname>Salazar</surname><given-names>F.</given-names></name><name><surname>Brown</surname><given-names>G.D.</given-names></name></person-group><article-title>T cell antifungal immunity and the role of C-type lectin receptors</article-title><source>Trends Immunol.</source><volume>41</volume><year>2020</year><fpage>61</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.it.2019.11.007</pub-id><pub-id pub-id-type="pmid">31813764</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T.</given-names></name><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Hoffman</surname><given-names>P.</given-names></name><name><surname>Hafemeister</surname><given-names>C.</given-names></name><name><surname>Papalexi</surname><given-names>E.</given-names></name><name><surname>Mauck</surname><given-names>W.M.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Stoeckius</surname><given-names>M.</given-names></name><name><surname>Smibert</surname><given-names>P.</given-names></name><name><surname>Satija</surname><given-names>R.</given-names></name></person-group><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><year>2019</year><fpage>1888</fpage><lpage>1902.e21</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Stubbington</surname><given-names>M.J.T.</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O.</given-names></name><name><surname>Regev</surname><given-names>A.</given-names></name><name><surname>Teichmann</surname><given-names>S.A.</given-names></name></person-group><article-title>Single-cell transcriptomics to explore the immune system in health and disease</article-title><source>Science</source><volume>358</volume><year>2017</year><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1126/science.aan6828</pub-id><pub-id pub-id-type="pmid">28983043</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>P.A.</given-names></name><name><surname>Levitin</surname><given-names>H.M.</given-names></name><name><surname>Miron</surname><given-names>M.</given-names></name><name><surname>Snyder</surname><given-names>M.E.</given-names></name><name><surname>Senda</surname><given-names>T.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Cheng</surname><given-names>Y.L.</given-names></name><name><surname>Bush</surname><given-names>E.C.</given-names></name><name><surname>Dogra</surname><given-names>P.</given-names></name><name><surname>Thapa</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Single-cell transcriptomics of human T&#x000a0;cells reveals tissue and activation signatures in health and disease</article-title><source>Nat. Commun.</source><volume>10</volume><year>2019</year><fpage>4706</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-12464-3</pub-id><pub-id pub-id-type="pmid">31624246</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>A.</given-names></name><name><surname>Saito</surname><given-names>T.</given-names></name></person-group><article-title>CD4 CTL, a cytotoxic subset of CD4(+) T&#x000a0;cells, their differentiation and function</article-title><source>Front. Immunol.</source><volume>8</volume><year>2017</year><fpage>194</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2017.00194</pub-id><pub-id pub-id-type="pmid">28280496</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="other" id="sref51"><person-group person-group-type="author"><collab>The Human Protein Atlas</collab></person-group><article-title>RGS16 Immune Cell Type Expression, Monaco Dataset</article-title><ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org/ENSG00000143333-RGS16/immune+cell" id="intref0040">https://www.proteinatlas.org/ENSG00000143333-RGS16/immune+cell</ext-link><year>2019</year></element-citation></ref><ref id="bib52"><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Tibbitt</surname><given-names>C.A.</given-names></name><name><surname>Stark</surname><given-names>J.M.</given-names></name><name><surname>Martens</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Mold</surname><given-names>J.E.</given-names></name><name><surname>Deswarte</surname><given-names>K.</given-names></name><name><surname>Oliynyk</surname><given-names>G.</given-names></name><name><surname>Feng</surname><given-names>X.</given-names></name><name><surname>Lambrecht</surname><given-names>B.N.</given-names></name><name><surname>De Bleser</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway Th2 cells</article-title><source>Immunity</source><volume>51</volume><year>2019</year><fpage>169</fpage><lpage>184.e5</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2019.05.014</pub-id><pub-id pub-id-type="pmid">31231035</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Hu</surname><given-names>E.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>P.</given-names></name><name><surname>Dai</surname><given-names>Z.</given-names></name><name><surname>Feng</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>W.</given-names></name><name><surname>Zhan</surname><given-names>L.</given-names></name><etal/></person-group><article-title>clusterProfiler 4.0: a universal enrichment tool for interpreting omics data</article-title><source>Innovation</source><volume>2</volume><year>2021</year><fpage>100141</fpage><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id><pub-id pub-id-type="pmid">34557778</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Zemmour</surname><given-names>D.</given-names></name><name><surname>Kiner</surname><given-names>E.</given-names></name><name><surname>Benoist</surname><given-names>C.</given-names></name></person-group><article-title>CD4<sup>+</sup> T<sub>eff</sub> heterogeneity: the perspective from single-cell transcriptomics</article-title><source>Curr.Opin.Immunol.</source><volume>63</volume><year>2020</year><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2020.02.004</pub-id><pub-id pub-id-type="pmid">32259715</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Zemmour</surname><given-names>D.</given-names></name><name><surname>Zilionis</surname><given-names>R.</given-names></name><name><surname>Kiner</surname><given-names>E.</given-names></name><name><surname>Klein</surname><given-names>A.M.</given-names></name><name><surname>Mathis</surname><given-names>D.</given-names></name><name><surname>Benoist</surname><given-names>C.</given-names></name></person-group><article-title>Single-cell gene expression reveals a landscape of regulatory T&#x000a0;cell phenotypes shaped by the TCR</article-title><source>Nat. Immunol.</source><volume>19</volume><year>2018</year><fpage>291</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0051-0</pub-id><pub-id pub-id-type="pmid">29434354</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M.J.</given-names></name><name><surname>Ntranos</surname><given-names>V.</given-names></name><name><surname>Tse</surname><given-names>D.</given-names></name></person-group><article-title>Determining sequencing depth in a single-cell RNA-seq experiment</article-title><source>Nat. Commun.</source><volume>11</volume><year>2020</year><fpage>774</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-14482-y</pub-id><pub-id pub-id-type="pmid">32034137</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Lan</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Quan</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>E.</given-names></name><name><surname>Deng</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Liao</surname><given-names>G.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><etal/></person-group><article-title>CellMarker: a manually curated resource of cell markers in human and mouse</article-title><source>Nucleic Acids Res.</source><volume>47</volume><year>2019</year><fpage>D721</fpage><lpage>D728</lpage><pub-id pub-id-type="doi">10.1093/nar/gky900</pub-id><pub-id pub-id-type="pmid">30289549</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Paul</surname><given-names>W.E.</given-names></name></person-group><article-title>Heterogeneity and plasticity of T helper cells</article-title><source>Cell Res.</source><volume>20</volume><year>2010</year><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/cr.2009.138</pub-id><pub-id pub-id-type="pmid">20010916</pub-id></element-citation></ref></ref-list><sec id="appsec2" sec-type="supplementary-material"><title>Supplemental information</title><p id="p0270">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Document S1. Figures&#x000a0;S1&#x02013;S5 and Tables&#x000a0;S1&#x02013;S5</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
</p></sec><sec sec-type="data-availability" id="da0010"><title>Data and code availability</title><p id="p0030">
<list list-type="simple" id="ulist0015"><list-item id="u0030"><p id="p0035">Raw and integrated scRNAseq data is deposited in Gene Expression Omnibus (GEO) database and are publically available as of the date of publication. Accession numbers are listed in the <xref rid="sec4.1" ref-type="sec">key resources table</xref>.</p></list-item><list-item id="u0035"><p id="p0040">This paper does not report original code. Any additional information required to reanalyze the data reported in this paper is available from the <xref rid="sec4.2.1" ref-type="sec">lead contact</xref> upon request.</p></list-item></list>
</p></sec><ack id="ack0010"><title>Acknowledgments</title><p id="p0250">The authors thank Dr. Jenny Gumperz for her insight and expertise regarding natural killer T&#x000a0;cells and the University of Wisconsin-Madison Clinical Cancer Center, Flow Cytometry Core Facility (UWCCC) and Biotechnology Center for help with cell sorting and sequencing. Robert Gordon (Department of Pediatrics) assisted with graphic illustration. The <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100007923</institution-id><institution>UWCCC</institution></institution-wrap></funding-source> is supported by <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>NIH</institution></institution-wrap></funding-source> Shared Instrumentation Grant 1S100OD018202&#x02013;01 and University of Wisconsin Carbone Cancer CenterSupportgrant P30 CA014520. We also acknowledge support from NIH grants R01 AI130411, U01AI124299, R01 AI035681 (to B.K.); R01AI168370 (to B.K. and M.W.); R01 AI093553 (to M.W.); the <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/100007631</institution-id><institution>Canadian Institute for Advanced Research</institution></institution-wrap></funding-source> (CIFAR) to B. K.); the <funding-source id="gs7"><institution-wrap><institution-id institution-id-type="doi">10.13039/100007015</institution-id><institution>University of Wisconsin-Madison</institution></institution-wrap></funding-source> Institutional Clinical and Translational Science Award UL1 TR002373 (to C.D.); <funding-source id="gs8"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source> Postdoctoral Fellowship #835129 (to L. D.); <funding-source id="gs9"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000884</institution-id><institution>Cancer Research Institute</institution></institution-wrap></funding-source> Postdoctoral Fellowship (to X.H); and a <funding-source id="gs10"><institution-wrap><institution-id institution-id-type="doi">10.13039/100008028</institution-id><institution>University of Wisconsin School of Medicine and Public Health</institution></institution-wrap></funding-source> Pediatrics Fellow/Resident research grant (to T.W.).</p><sec id="sec5"><title>Author contributions</title><p id="p0255">T.W. and C.D. contributed scRNAseq analysis; C.D. contributed to TCR and gene velocity analysis; L.D., X.H., and H.D. contributed mouse and RT-PCR experimental data; T.W. drafted the manuscript; M.W. and B.K. conceived project and oversaw intellectual content; and all authors contributed to editing of manuscript.</p></sec><sec id="sec6"><title>Declarations of interests</title><p id="p0260">B. K. has an additional affiliation as Fellow of the Canadian Institute for Advanced Research (CIFAR). The authors have no other declarations or conflicts of interest to disclose.</p></sec></ack><fn-group><fn id="appsec1" fn-type="supplementary-material"><p id="p0265">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.isci.2022.104934" id="intref0025">https://doi.org/10.1016/j.isci.2022.104934</ext-link>.</p></fn></fn-group></back></article>
